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CHAPTER I 
INTRODUCTION 
A number of thioxanthenone derivatives are known to possess 
schistosomicidal, carcinostatic, and bacteriostatic activities. 
Miracil D, as one of the most potent thioxanthenones, and its congeners 
have been the subject of intense investigations for nearly three 
decades. The majority of the investigations have been concerned 
mainly with the biological effects of these compounds. Their mode of 
action at the molecular level is not understood yet. This dissertation 
represents an effort to correlate some of the physicochemical and bio-
logical properties of two thioxanthenones (see section I.8). 
I.1. The Structure of Thioxanthenone 
Thioxanthenone (Figure 1) has a permanent electric dipole moment 
0 
of 2.59 Debeyes in benzene at 25 C (Aroney et al., 1971). Assuming the 
participation of the d-orbitals of the sulfur atom in the formation of 
molecular orbitals, the bond order of the carbonyl C=O bond is calcu-
lated to be close to that of a carbon-carbon bond of benzene (Given et 
al., 1965). These findings suggest that the thioxanthenone molecule is 
best desc.ribed by the resonance structures shown in Figure 2. This de-
localization of electrons leads to a charge distribution with permanent 
electric dipole moment, the vector of which is located along the C9-S10 
axis. In addition, the possibility that a conjugated double bond 
system forms over the three rings lends credibility to a planar three-
ring structure. Although this possibility was doubted lately (Aizen-
1 
2 
Figure 1. The structural formula of thioxanthenone (10-thioxanthene-
9-one). 
3 
4 
Figure 2. Resonance structures for thioxanthenone. 
5 
-101 
I (X)) 
- + 
shtat et al., 1972), no good evidence exists to suggest that the thio-
xanthenone ring is not planar. 
6 
The importance of the exocyclic oxygen atom in maintaining the 
planar ring structure can be demonstrated by the comparison of the thio-
xanthenone and thioxanthene (Figure 3) system. Thioxanthene is also a 
polar molecule, but based on the measurement of dipole moments it has 
been concluded that the molecule is definitely not planar (Aroney et 
~· 1969). In fact, the dihedral angle determined by the planes of the 
two benzene rings is calculated to be 135 ° in carbon tetracholride and 
160 ° in benzene. NMR measurements have provided evidence that the 
molecule rapidly inverts between the two possible dihedral conformations 
(Aizenshtat et al., 1972). 
I.2. The Structure and Physicochemical Properties of Thioxanthenone 
Derivatives 
Miracil D (Kikuth et al., 1946) is the trade name (Bayer) for 
1-(4-ethyl-1,4-diazahexyl)-4-methyl-10-thioxanthene-9-one (Figure 4). 
It is also marketed under the trade names Nilodin (Burroughs Wellcome) 
and Lucanthone (Calbiochem). This crystalline yellow solid has a mole-
cular weight of 376.7 daltons (as monohydrochloride) and is soluble in 
water up to 1-2% (Blair, 1958; Hawking and Ross, 1948). Salts 
decrease its solubility (Lea et al., 1972). Its melting point varies 
between 195 and 197 °C according to different authors (Blanz and 
French, 1963; Mauss, 1948; Sharp, 1951). Infrared spectroscopy studies 
suggest that in the solid phase the distal nitrogen atom in Miracil D 
monohydrochloride is protonated (Zilversmit, 1970). 
In aquaeous solution both nitrogen atoms of Miracil D partici-
7 
Figure 3. The structural formula of 10-thioxanthene. 
8 
9 
Figure 4. The structural formula of Miracil D (1-(4-ethyl-1,4-di-
azahexyl)-4-methyl-10-thioxanthene-9-one). 
0 
II (XC 9 I 10 
s 
CH 3 
10 
11 
pate in acid-base equilibria. The pKa of the proximal nitrogen atom 
was determined spectrophotometrically and found to be -0.20 (Zilver-
smit, 1970). Since the free base is not soluble in water, the pKa of 
the distal nitrogen atom was determined from titration curves in etha-
nol-water mixtures (Munro, 1961). Extrapolation to pure water gave a 
pKa of 7.4. 
On the basis of electronic and vibrational spectral studies, 
Zilversmit found that the hydrogen atom on the proximal nitrogen atom 
forms an intramolecular hydrogen bond with the carbonyl oxygen of 
Miracil D, and the trigonal proximal nitrogen atom is coplanar with the 
heterocyclic ring system (Zilversmit, 1971). 
The tendency of Miracil D to form aggregates in aquaeous so-
lutions was noted in the work of Scholtan (Scholtan, 1959). In this 
study, sedimentation and diffusion coefficient measurements were com-
bined to assess the degree of aggregation. However, the conditions 
used for these studies were not carefully defined and the validity of 
the quantitative findings is open to some question. 
Methyl substitution on the proximal nitrogen atom of Miracil D 
leads to a conformational change in the molecular structure. The 
structure of methyl-Miracil D (Figure 5a) does not permit the formation 
of an intramolecular hydrogen bond. The steric interference between 
the methyl group and the oxygen atom of the carbonyl group necessitates 
a rotation of the amine side chain on the C1-proximal nitrogen atom 
bond axis to permit these substituents to achieve their Van der Waals 
separation (Zilversmit, 1970). As a result of this rotation, the 
conjugation of the lone electron pair of the proximal nitrogen atom to 
12 
Figure 5a. The structural formula of methyl-Miracil D (1-(4-ethyl-
1-methyl-1,4-diazahexyl)-4-methyl-10-thioxanthene-9-one). 
CH 3 
13 
the aromatic ring system is reduced, and the electron density of the 
nitrogen atom is increased. The pKa of the proximal nitrogen atom is 
3 .41 contrasted with a corresponding value of -0.20 for Miracil D. 
14 
MDMT (1-(4-methyl-1,4-diazapentyl)-4-methyl-10-thioxanthene) 
(Figure 5b), although not a thioxanthenone, will also be considered in 
this investigation. The MDMT molecule contains the 10-thioxanthene 
ring structure (Figure 3), and, therefore, the MDMT molecule is not 
planar but rather the molecule rapidly inverts between the two possible 
dihedral conformations (see section 1.1). The purpose of this selection 
is to examine the effect of ring puckering on the intercalation process 
(see section 1.6.2) and on the inhibiton of DNA dependent RNA synthe-
sis. 
!.3. Schistosomicidal Activity of Thioxanthenones 
Schistosomes (Class Trematoda, Genus Schistosoma) are parasites 
which pass through a number of stages in their development. Several 
species of animals serve as hosts. In the disease schistosomiasis 
(also called bilharziasis), schistosomes penetrate the blood vessels of 
the urinary bladder, intestines, liver, and spleen of their hosts. 
Certain snails, in which the schistosomes spend one of their life 
cycles, act as intermediate hosts in the transmission of the disease. 
A particular segment of human populations, mostly in tropical 
countries, is infected by the species S. mansoni (South America), 
S. haematobium (Egypt), and S. japonicum (Philippines). 
The discovery of the family of Miracils emerged from the world-
wide need for the treatment of schistosomiasis. Miracil D proved to be 
the most potent member of the family against S. mansoni infections in 
15 
Figure Sb. The structural formula of MDMT (1-{4-methyl-1,4-diaza-
pentyl)-4-methyl-10-thioxanthene). 
CH 3 
16 
17 
mice and monkies as judged from the decrease of egg secretion in feces 
(Kikuth et al., 1946). Autopsy revealed that upon treating with the 
drug, the mature schistosomes lose their motility, decrease in size, 
and become fragile (Kikuth and G8nnert, 1948). The chief points of 
drug attack are the sex- and yolk-cells. Clinical trials were also 
succesful in humans (Blair, 1958). Investigations on the structure-ac-
tivity relationship of thioxanthenones showed that activity depends on 
the genus of the host, even when the same strain of the parasite is 
used for infection (GBnnert, 1961). However, an absolute requirement 
for the 4-methyl group of Miracil D is present. 
The host-dependent structure-activity relationship engendered 
metabolic studies of Miracil D in different species to examine the 
possibility that the drug was converted to an active agent in vivo. 
In mammalian organisms, there are three major metabolic pathways for 
Miracil D: hydroxylation of the 4-methyl group, desethylation of the 
terminal side chain nitrogen, and sulfoxidation (Rosi et al., 1967). 
The first of these appears crucial for the in vivo activation of 
l1iracil D, since the hydroxylated derivative, Hycanthone (Figure 6), is 
significantly more active than the parent compound. This clarifies 
the absolute requirement for the 4-methyl group mentioned earlier. 
Recently it was found that Hycanthone is an inhibitor of acetyl-
choline receptors of the nervous system in S. mansoni (Hillman and 
Gibler, 1975). 
1.4. Carcinostatic Activity of Thioxanthenones 
In early experiments, Miracil D was found effective in retarding 
the growth of the Walker rat carcinoma, less effective against a benzo-
18 
Figure 6. The structural formula of Hycanthone (1-(4-ethyl-1,4-di-
azahexyl)-4-hydroxymethyl-10-thioxanthene-9-one). 
19 
pyrene induced rat sarcoma, and entirely inactive against the solid 
form of the Ehrlich carcinoma in mice (Hackman et al., 1949). 
In a subsequent more extensive study, ~tlracil D was found to 
20 
exhibit a wide spectrum of carcinostatic activity against a variety of 
transplantable mouse tumors at non-toxic dosage levels (Hirschberg et 
~' 1959). Sarcoma 180 and lymphoid leukemia Ll210 ascites respond 
most readily, followed by Adenocarcinoma 755 and E0771. Glioma 26 and 
the Ehrlich ascites carcinoma show a marginal response at best. Seven-
teen other thioxanthenones have been compared to Miracil D in terms of 
cytotoxicity in tissue cultures of human and mouse brain tumors, maxi-
mum tolerated dosage levels in the mouse, and carcinostatic activity 
against a variety of mouse tumors. None of the analogues approaches 
the pronounced activity of Miracil D in vivo. In tissue culture, how-
ever, many of the thioxanthenones are more active than the parent 
compound. No correlation was found between in vivo and in vitro car-
cinostatic activity, and schistosomicidal activity. 
Studies, such as the above, were later extended to forty-four 
thioxanthenone derivatives (Blanz and French, 1963). As a result of 
these investigations, the following generalities, regarding the 
structures of the more effective antitumor derivatives, were formu-
lated for leukemia L1210, Adenocarcinoma 755, and Sarcoma 180: 
(a) the carbon chain between the nitrogen atoms of the side 
chain of the thioxanthenone molecule must be two carbon atoms in length, 
(b) the terminal alkyl group(s) must be small, 
(c) the ring attached nitrogen atom must bear one hydrogen atom, 
(d) there must be an unsubstituted sulfur atom in position 10, 
21 
(e) there must be a carbonyl group in position 9, and 
(f) there must be a compact, fairly chemically stable substitu-
ent in position 4. 
These structural characteristics lead to the speculation that the metal 
chelating ability via the carbonyl group and the dialkylaminoethyl-
amino chain may be essential for carcinostatic activity. 
Subsequently it was established that the carcinostatic activity 
of Miracil D against leukemia L1210 in mice was completely abolished by 
the simultaneous administration of nontoxic doses of SKF 525-A (S-di-
ethylaminoethyl diphenylpropylacetate hydrochloride) (Hirschberg et 
al., 1964). Since SKF 525-A inhibits microsomal enzyme systems which 
catalyze a variety of metabolic transformations of drugs, this obser-
vation suggests that ~~racil D is converted in vivo to an active me-
tabolite before eL~ibiting its carcinostatic activity. In search of 
the carcinostatic metabolite of Miracil D, Hirschberg and his coworkers 
investigated the products formed in mammalian metabolism of Miracil D 
(Hirschberg et al.t 1968). None of the metabolites, including Hycan-
thone, proved superior to Uiracil D. No correlation was found between 
the schistosomicidal and the carcinostatic activities of these drugs. 
Miracil D has been found to cause a concentration dependent in-
hibition of DNA and RNA synthesis in leukemia L1210 ascite cells of 
mice (Wilson et al., 1972). The drug inhibits DNA synthesis to a 
greater extent than RNA synthesis in contrast to analogous findings in 
bacteria. Hethyl-Uiracil D was much less effective while Hycanthone 
behaved similarly to ~:iracil D (~Ulson et al., 1975). 
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l·5· Bacteriostatic Activity of Thioxanthenones 
Miracil D inhibits the growth of B. subtilis (Weinstein et al., 
1955), E. coli (Weinstein et al., 1967), S. typhimurium (Hartman~ 
al., 1973), and the slime mold D. discoideum (Hirschberg et al., 1968). 
-------
At the same time, Miracil D causes complete inhibition of total cellu-
lar RNA synthesis and partial inhibition of DNA and protein syntheses, 
and blocks the induction of ~-galactosidase in E. coli (Weinstein et 
~' 1967). In B. subtilis, the growth inhibition is accompanied by 
the complete inhibition of RNA synthesis and the partial inhibition of 
protein synthesis (Weinstein et al.,1955). DNA synthesis is not in-
hibited in the first 20 minutes of an exponentially growing culture. 
However, after 20 minutes DNA synthesis is also inhibited (Haidle et 
al., 1970). From transformation experiments using donor DNA from cells 
grown in the presence of Miracil D, it was concluded that in~ 
subtilis the drug permits the DNA molecules in the process of repli-
cation to complete the process, but prevents the reinitiation of 
chromosome replication. Although protein synthesis, using natural or 
synthetic m-RNA, is not inhibited by the drug in subcellular systems 
(Weinstein et al., 1967), the prevention of reinitiation of chromosome 
replication is ascribed to the rapid inhibition of RNA synthesis .and 
the subsequent inhibition of protein synthesis (Weinstein and Hirsch-
berg, 1971). 
The possibility that Miracil D affects the utilization of ~lA 
precursors in vivo was excluded by investigating the inhibition of DNA . 
dependent RNA polymerase of E. coli in vitro (Weinstein et al.,1967). 
It was found indeed that the drug inhibits RNA polymerase in vitro. 
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In addition, supplementation of the system with excess DNA reversed the 
inhibition, whereas supplementation with excess enzyme did not, indi-
eating that the target of drug action is the DNA and not the enzyme. 
Methyl-Miracil D also inhibits the growth of B. subtilis, but 
to a much lesser degree than Miracil D (Hirschberg et al., 1968). In 
contrast with the parent compound, methyl-Miracil D is reported not to 
inhibit RNA synthesis in vitro. 
1.6. The Interaction of Thioxanthenones with Nucleic Acids 
!.6.1. Physicochemical Evidence for the Interaction of Thioxanthenones 
with Nucleic Acids 
Direct evidence for the interaction between Miracil D and nucleic 
acids has been obtained from the spectrophotometric studies of Wein-
stein and his coworkers (Weinstein et al., 1965). Miracil Din 0.33 ~~ 
phosphate buffer, pH 6.8 exhibits absorption maxima at 330 and 442 nm. 
Upon addition of calf thymus DNA, the maxima shift to longer wavelengths 
and the absorbances decrease at the maxima. At a DNA concentration of 
50 ~g/ml, the maxima are shifted to 337 and 450 nm, respectively. 
Qualitatively similar changes are produced by synthetic single stranded 
ribonucleic acids. However, some quantitative differences are noted 
among nucleic acids when compared with respect to their ability to in-
duce a shift in the absorption maximum of Miracil D from 330 to 337 nm. 
At high polymer concentrations the order of relative effectiveness is: 
DNA > poly A > poly U > poly C. At lower polymer concentrations poly A 
appeared to be the most effective in this respect. 
Miracil D also has been found to stabilize native calf thymus DNA 
from heat denaturation (Weinstein et al., 1965). For example, in a 
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buffer of low ionic strength and at a Miracil D concentration of 
4 pg/ml, the melting temperature of DNA increases from 56 to 79 °c. 
Methyl-Miracil D is much less effective in this respect (Hirschberg et 
1 1968) High ionic strength and addition of the tetramine spermine a., . 
-------
seem to abolish the stabilizing effect. 
Miracil D and Hycanthone cause an increase in the intrinsic 
viscosity of native calf thymus DNA. Methyl-Miracil D did not increase 
the intrinsic viscosity of DNA under similar conditions (Carchman et 
~' 1969). The addition of spermine , as well as magnesium and sodium 
ions reverses the effect of ~uracil D and Hycanthone on DNA viscosity. 
The significance of these data might be in some doubt in view of the 
fact that the measurements were not carried out at constant drug-DNA 
binding ratios. 
I.6.2. The Intercalation of Thioxanthenones with Nucleic Acids 
In 1961 Lerman proposed a model for the interaction of acridines 
with DNA (Lerman, 1961). According to this model, the acridine mole-
cules, which possess planar heterocyclic ring systems, intercalate be-
tween adjacent base pairs in DNA. The intercalation is accompanied by 
an unwinding of the double helix, which, however, leaves the hydrogen 
bonded base pairing intact. This model is consistent with the X-ray 
diffraction patterns of DNA-proflavine fibers, as well as the increase 
in the intrinsic viscosity, and the decrease in the sedimentation 
coefficient of DNA in the presence of acridines. 
On the basis of the experimental findings presented in the pre-
ceding section, it was proposed that Miracil D intercalates forming a 
complex, in which the thioxanthenone ring system is located between ad-
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jacent DNA base pairs (Weinstein and Hirschberg, 1971). In this 
complex, the positively charged distal nitrogen atom of the side chain 
interacts with the negatively charged phosphate residues of the DNA 
backbone. 
In the intercalated Miracil D-DNA complex, the Miracil D mole-
cules should be oriented parallel to the base pairs and perpendicularly 
to the long axis of DNA. Indeed, flow dichroism studies have suggested 
that the Miracil D chromophore is oriented perpendicularly to the long 
axis of DNA, i.e. it is coplanar with the base pairs (private communi-
cations to Weinstein and Hirschberg, 1971). This observation serves as 
additional evidence that Miracil D interacts with DNA by intercalation. 
The intercalation model for Miracil D has been further sup-
ported, though indirectly, by the sedimentation experiments of Waring 
(Waring, 1970). The replicative form (RF I) of bacteriophage ~X 174 
DNA consists of a covalently closed circular double helix. In addition 
to the Watson-Crick type helical turns of the strands, the double helix 
of the RF I form is folded into supercoils or superhelical structures. 
Because of topological pecularities, characteristic of circularity, 
this kind of DNA molecule displays large changes in supercoiling in 
response to intercalation induced local unwinding of the helix. Spe-
cifically, during the first phase of drug binding to superhelical DNA, 
the number of right-handed supercoils, originally present in DNA, de-
creases. At a certain level of binding, all supercoils are removed. 
As further drug binding takes place, left-handed supercoils begin to 
appear. Since the supercoiled DNA molecules, no matter whether they 
are left- or right-handed, are more compact than the DNA molecules with-
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out supercoils, they sediment more rapidly. Therefore, the loss or re-
appearance of supercoiling can be observed by monitoring changes in the 
sedimentation coefficient. 
The hydroxylated derivative of Miracil D, Hycanthone, exhibits 
this characteristic property of intercalating drugs (such as ethidium 
bromide, propidium iodide, proflavin, etc.) on the sedimentation coef-
ficient of the closed circular duplex. The intercalation of one Hycan-
thone molecule causes an unwinding of 16.4 ° (corrected value) in the 
angle of the helix*. Lately four indazole analogues of Miracil D and 
Hycanthone were found to intercalate with DNA of bacteriophage PM2 
(Waring, 1973). Because of the relative insolubility of these ana-
logues, however, their binding to DNA has not been quantitated, and, 
therefore, the author reports only lower limits of the unwinding angles 
0 between 10.4 and 16.2 (corrected values, see footnote). These lower 
limits are compatible with an unwinding angle of 16.4 ° obtained for 
Hycanthone (see above). 
The double helical oligoribonucleic acid poly A•poly U also 
binds Miracil D through an intercalation process as concluded from N}m 
studies of such complexes (Heller et al., 1974). This conclusion was 
deduced from the shift and broadening of resonance of the 4-methyl 
group of the drug. Similar but weaker effects were observed with the 
single stranded oligoribonucleic acid poly A. No effect was discerni-
*Unwinding angles were initially calculated relative to an as-
sumed unwinding angle of 12 ° for ethidium bromide (Waring, 1970). 
However, since this value was more recently modified to 29 ° (Tsai et 
al., 1975), previously reported unwinding angles must be multiplied~y 
a factor of 29/12=2.42 to obtain the corrected values. 
ble with the single stranded oligoribonucleic acid poly u: 
Based on these observations, a structure for the Miracil D-
poly A•poly U complex was suggested, in which carbons 1, 2, 3, and 4 
of the thioxanthenone ring are located between the adenine bases, and 
the diethylaminoethylamino side chain portion extends from the major 
groove of the helix (Figure 7). This orientation allows a complete 
intercalation of the thioxanthenone ring system between the stacked 
base pairs, and allows the distal nitrogen atom of the side chain to 
reach near the phosphate oxygen atoms of the polymer, making electro-
static interaction between these groups possible. 
I.6.3. The Effect of the Intercalation between Thioxanthenones and 
Nucleic Acids on RNA Synthesis 
27 
In the enzymatic synthesis of RNA catalyzed by DNA dependent RNA 
polymerase (enzyme), the enzyme directs the synthesis of &~A from mono-
nucleoside triphosphates according to genetic information encoded in 
the template. The synthesis may be visualized as consisting of a 
number of steps. The commonly accepted steps are (Chamberlin, 1974): 
(1) Template (i.e. DNA) binding, in which the enzyme (i.e. RNA poly-
merase) attaches to the DNA template, locates a specific site at which 
chain initiation can occur, and assumes an active conformation. (2) 
RNA chain initiation, in which the enzyme catalyzes the coupling of 
ATP or GTP with a second ribonucleoside triphosphate (substrate). In-
organic pyrophosphate is eliminated and a dinucleoside tetraphosphate 
is produced. This moiety remains tightly bound to the enzyme-template 
complex. (3) RNA chain elongation, in which successive nucleoside 
monophosphate residues are added from the substrate nucleoside tri-
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Figure 7. The structure of the Uiracil D-poly A•poly U complex. The 
Miracil D molecule is intercalated between two adjacent base pairs 
(Heller et al., 1974). 
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phosphates to the 3'-0H terminus of initial dinucleoside tetra-
phosphate leading to elongation of the nascent RNA chain. (4) RNA 
chain termination and enzyme release, in which the newly formed EllA 
chain and enzyme are released from the template. 
30 
As a result of the formation of complexes between thioxanthe-
nones and nucleic acids, the template activity of nucleic acids in RNA 
synthesis is affected. The DNA dependent RNA polymerase of E. coli 
using calf thymus DNA as template is inhibited by Miracil D (Weinstein 
et al., 1967). This inhibition can be ascribed exclusively to the 
interaction of Miracil D with the template DNA since supplementation of 
the system with excess DNA reverses the inhibition, whereas supple-
mentation with excess enzyme does not, indicating that the target of 
drug action is the template and not the enzyme. Methyl-Miracil D 
produces no apparent inhibition in the same system under similar con-
ditions (Hirschberg et al., 1968c). 
Wilson and his coworkers investigated the effectiveness of 
Miracil D as inhibitor of &~A synthesis using synthetic single and 
double stranded ribo- and deoxyribonucleic acids (Wilson et al., 
1972b). In general, inhibition was most pronounced for polynucleotides 
containing deoxyribose and adenine. Specifically, for double stranded 
polydeoxyribonucleotides the following order of relative inhibition was 
observed: calf thymus DNA <poly dG•poly dC < poly dA•poly dT < 
poly d(A-T). The authors concluded that Miracil D has a great affinity 
for adenine residues. 
1·7· Circular Dichroism of Drug-DNA Complexes 
1.1.1. Circular Dichroism Definitions 
One manifestation of optical activity is that optically active 
compounds or complexes absorb the left and right circularly polarized 
lights to different extent. This manifestation is termed circular 
dichroism. If Beer's law is obeyed for these two kinds of lights, 
we have 
Ay. =~ • c • 1 and 
~=1\·c•l , 
where ~, ~ and ~' ~ are the absorbances and molar extinction 
coefficients, respectively, c is the molar concentration of the 
substance exhibiting circular dichroism, and 1 is the path length in 
em. The subscripts L and R refer to the left and right circularly 
polarized lights, respectively. From these equations, we obtain 
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The quantity~-~ is called differential absorbance and~-~ is 
called differential molar extinction coefficient, expressed in units of 
-1 -1 
absorbance and liter•Hole •em , respectively. In general, the 
differential molar extinction coefficient EL-ER is used to express 
the circular dichroism properties of these optically active substances. 
As a consequence of the difference in extinction coefficients 
for the left and right circularly polarized lights, substances ex-
hibiting circular dichroism polarize the plane polarized light el-
liptically, that is, if a plane polarized light beam passes through 
r t::. 32 
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~.~.; ) these substances, the emerging light becomes elliptically· polarized. 
The major axis of the ellipse is also rotated with respect to the 
plane of the incident plane polarized light, resulting in optical 
rotation. The ellipticity 0 (the ratio of the minor to the major axis 
of the ellipse) of the emerging elliptically polarized light can be 
expressed, if Beer's law is obeyed, as 
0=[0]•c•l , 
where 0 is the ellipticity in degrees, c is the molar concentration of 
the substance, and [0] is the molar ellipticity in deg•lit•Hole-l• 
-1 
em 
The molar ellipticity [0] and the differential molar extinction 
coefficient EL-ER are related according to the equation 
Clearly then, in addition to the differential molar extinction coef-
ficient, the molar ellipticity can be used to quantitate the circular 
dichroism properties of optically active substances. 
1.7.2. Optical Activity of Drug-DNA Complexes 
Many drug and dye molecules that are themselves optically in-
active, become active when bound to DNA. Typical examples are ethidium 
bromide (Al~tipis and Martz, 1970), proflavine, acridine orange (Blake 
amd Peacocke, 1966), and the aminoacridines (Dalgleish et al., 1969). 
All these molecules are derivatives of planar heterocyclic ring 
systems, and are known to interact with DNA by intercalation. For the 
characterization of the complexes formed, the concept of the binding 
ratio is a useful parameter. The binding ratio r is defined as 
r = 
~ 
[P] 
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where cb is the concentration of drug or dye bound to the nucleic acid~ 
and [PJ is the nucleic acid concentration expressed as nucleic acid 
phosphorous (Scatchard, 1949). This quantity is proportional to the 
degree of saturation of nucleic acids by the ligand. If the ligand 
exhibits no preference for binding sites of a particular composition, 
then the distribution of bound molecules on a linear polymer nucleic 
acid can be considered as random. Therefore, in this case, the binding 
ratio r would be inversely proportional to the average physical 
distance between bound molecules. 
In the circular dichroism spectra of aminoacridine-DNA and 
ethidium bromide-DNA complexes, two kinds of circular dichroism bands 
have been described: (1) those, the differential molar extinction coef-
ficients of which are relatively independent of the binding ratio r, 
and (2) those, the differential molar extinction coefficients of which 
steeply increase with increasing binding ratios. In the first instance, 
the induced circular dichroism appears to be the result of direct 
interactions between the symmetric intercalated molecule and the asym-
metric binding site of DNA (Jackson and }fuson, 1971). The value of 
EL-ER for an isolated intercalated molecule (which in practice is the 
value of E1 -ER at very low r values) is not affected by the presence of 
molecules bound to the neighbouring sites. In the second case, the in-
duced circular dichroism is the result of an interaction between mole-
!·. . 34 cules intercalated at neighbouring binding sites (Jackson "and ~~son, 
~ ~-' 1971). In this case, the differential molar extinction coefficients 
are zero or nearly zero at an r of 0 and increase rapidly with in-
creasing binding ratios up to saturation (Dalgleish et al., 1969; 
Aktipis and Kindelis, 1973). Either type or both types of bands ap-
pear in the circular dichroism spectra of these compounds when bound 
to DNA. 
1.8. The Scope of This Investigation 
As mentioned earlier in this chapter, a number of attempts have 
been made to correlate the schistosomicidal, the carcinostatic and the 
bacteriostatic activities of thioxanthenones. However, there does not 
seem to be a unique mechanism responsible for all these activities. 
The biochemical basis of the schistosomicidal and carcinostatic activi-
ties remains elusive. 
The bacteriostatic activity of thioxanthenones, however, appears 
to be related to the inhibition of cellular RNA synthesis. Especially 
in the case of two well-investigated thioxanthenones, Miracil D and 
methyl-Miracil D, a good correlation can be obtained between bacteria-
static activity and the effectiveness of these compounds as inhibitors 
of RNA synthesis. A puzzling aspect among the results of previous 
studies has been the reported almost complete ineffectiveness of 
methyl-~firacil D in inhibiting RNA synthesis compared to }-uracil D. 
Therefore, this investigation was undertaken to determine whether the 
observed differences in the inhibition of RNA synthesis by Miracil D 
and methyl-Hiracil D could be related to the physicochemical properties 
of the complexes formed ben1een these drugs and DNA, and whether the 
~-
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lack of inhibitory effectiveness of methyl-Miracil D could be explained 
on the basis of the physicochemical properties of this drug. 
In this investigation, the drug-DNA complexes are examined by 
means of absorption spectroscopy, circular dichroism, and melting 
profiles. The results of binding studies between DNA and the thio-
xanthenones are used to interpret the relationship between the physi-
cochemical properties of drug-DNA complexes and the inhibitory ef-
fectiveness of these drugs. Circular dichroism measurements are uti-
lized to investigate the structural features of drug-DNA complexes with 
special regard to long range changes in DNA conformation leading to ex-
clusion in binding. Melting profiles of these complexes are studied in 
order to establish the relative effectiveness of Miracil D and its 
methyl derivative, when bound to DNA, in stabilizing DNA against heat 
denaturation, and to obtain insight into the mechanism of inhibiton of 
RNA chain elongation by these drugs. 
The inhibition of both initiation and elongation of RNA synthe-
sis by these drugs is also investigated. Miracil D is found to in-
hibit both initiation and elongation of RNA synthesis. Finally, it is 
established that Miracil D and its methyl derivative, when bound to 
DNA, are equally effective inhibitors of RNA synthesis. 
: ,· 
CHAPTER II 
MATERIALS AND METHODS 
II.l. Materials 
Calf thymus deoxyribonucleic acid as a white fibrous material 
was purchased from Worthington Biochemical Corporation (Freehold, New 
Jersey 07728) and Sigma Chemical Company (Saint Louis, Missouri 63178). 
Bacteriophage T2 (ATCC No. 11303 B2 ; Host: E. coli B, ATCC No. 
11303) as a suspension in 0.05 M Tris buffer, pH 7.6, containing 0.1 M 
NaCl and 1 mM EDTA, was obtained from Miles Laboratories, Inc. (Elkhart, 
Indiana 46514). The suspension (Control No. 21-6-790) had a titer of 
5x1o12 plaque forming units per ml and an absorbance of 43 per ml at 
260 nm. 
DNA dependent RNA polymerase (Nucleosidetriphosphate: RNA 
nucleotidyltransferase; E.C. No. 2.7.7.6) from E. coli, strain K-12 
was purchased from Sigma as a solution in 50 % glycerol and 50 % 0.01 M 
Tris buffer, pH 7.9, containing 0.01 M MgC12 , 0.1 M KCl, 0.1 ~1 dithio-
threitol, and 0.1 m}1 EDTA. The enzyme solution (Lots No. 33C-2510 and 
94C-0284-2) had specific activities of 382 and 565 units/mg, and prote-
in concentrations of 2.10 and 1.77 mg/ml, respectively. One unit of 
enzyme will incorporate 1 nMole of labeled ATP into an acid insoluble 
0 product in 10 minutes at pH 7.9 and 37 C, using calf thymus DNA as 
template (Burgess, 1969). 
Miracil D (1-(4-ethyl-1,4-diazahexyl)-4-methyl-10-thioxanthene-
9-one) as a yellow crystalline solid was purchased from Calbiochem 
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(La Jolla, California 92037) under the trade name Lucanthone, as hydro-
chloride, with a molecular weight of 376.7 daltons (Lot No. 802205). 
Methyl-:Hiracil D (1-{4-ethyl-1-methyl-1,4-diazahexyl)-4-methyl-
10-thioxanthene-9-one) and MDMT {1-{4-methyl-1,4-diazapentyl)-4-methyl-
10-thioxanthene) as crystalline solids were generous gifts from Dr. 
Edward Elslager of Park, Davies & Company (Ann Arbor, Michigan 48106) 
and Dr. Frederic A. French of Mount Zion Hospital and Medical Center 
(San Francisco, California 94115), respectively. Methyl-Miracil D was 
supplied as dihydrochloride monohydrate with a molecular weight of 
445.45 daltons and MD}IT as the free base with a molecular weight of 
298.44 daltons. 
Sodium salts of the four nucleoside triphosphates ATP, CTP, GTP, 
and UTP as white crystalline solids were purchased from Sigma and 
P-L Biochemicals, Inc. {Milwaukee, Wisconsin 53205). The preparations 
were at least 97 % pure according to the manufacturer's specifications. 
5-[3H]-uridine-5'-triphosphate, tetrasodium salt (specific 
activity: 19 Ci/mMole) in ethanol-water (1:1) mixture was obtained 
from Schwarz/Mann {Orangeburg, New York 10962). 
y-[ 32P]-adenosine-5'-triphosphate, ammonium salt (specific ac-
tivity: 15.8 Ci/~wle) as freeze-dried solid was purchased from 
Amersham/Searle Corporation (Arlington Heights, Illinois 60005). 
All common chemicals used were of analytical grade. 
II.2. Instruments 
The following instruments were used in these studies: 
Cary Model 15 Recording Spectrophotometer (Varian, Cary Instru-
ments Division, Monrovia, California 91016) 
Jasco Hodel ORD/UV-5 Optical Rotatory Dispersion Recorder 
(Japan Spectroscopic Company, Ltd., Tokyo, Japan) equipped with CD 
attachement and modified (SS-10 modification) to a maximum sensi-
tivity of 0.002 degrees of ellipticity per em 
Beckman :Hodel LS-250 Liquid Scintillation System (Beckman 
Instruments, Inc., Fullerton, California 92634) 
Beckman TM Analyzer (Beckman Instruments, Inc., Fullerton, 
California 92634) 
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Beckman Temperature Bridge (Beckman Instruments, Inc., Fullerton, 
California 92634) 
¥~seley Model 7035B X-Y Recorder (Hewlett Packard Corporation, 
Palo Alto, California 94304) 
International Model PR-2 Portable Refrigerated Centrifuge 
(International Equipment Company, Needham Heights, Massachusetts 02194) 
Beckman/Spinco Model L Ultracentrifuge (Beckman Instruments,Inc. 
Spinco Division, Palo Alto, California 94304} 
Corning Model 12-B Research pH Meter (Corning Scientific 
Instruments, Medfield, Massachusetts 02052) 
Lauda/Brinkman 110del K-2/R Refrigerated Circulator (Brinkman 
Instruments, Inc., Westbury, New York 11590) 
11.3. Purification of Miracil D 
Miracil D (0.4 g) was dissolved in 50 ml distilled water at 
50 °C. The solution was titrated with 50 % sodium hydroxide solution 
until no further precipitation was observed (about pH 11). The pre-
cipitate was collected on a sintered glass filter and redissolved in 
absolute ethanol at 50 °C. Concentrated hydrochloric acid (10 rnl) was 
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f added and the Miracil D 'tvas crystallized at 4 °c. The crystals were 
r.-· 
dried over Drierite dessicant (anhydrous Caso4) and stored in a dark 
bottle at 4 °C. 
Thin layer chromatography was performed in the following solvent 
systems (Zilversmit, 1970): butanol/acetic acid (9:1), chloroform/ 
methanol (9:1), ethyl acetate/n-heptane (6:4), and ethanol/ammonium 
hydroxide (9:1). No contaminants could be detected in the purified 
preparation. 0 The melting point was 195 C, in agreement with Mauss 
(Mauss, 1948). 
II.4. Preparation of Deoxyribonucleic Acid from Bacteriophage T2 
Deoxyribonucieic acid from bacteriophage T2 was prepared by the 
method of Bautz and Dunn (Bautz and Dunn, 1971). 
Commercial bacteriophage suspension (5 ml) was dialyzed versus 
2 liters of 0.1 M sodium phosphate buffer, pH 7.2 for 5 hours. The 
dialyzate was transferred into a 10 m1 test tube and 0.55 ml of 
freshly prepared 10 % sodium dodecyl sulfate solution was added. The 
mixture was then placed into a water bath and the temperature was 
raised to 65 °C. The mixture after three minutes at this temperature 
became quite viscous. After chilling on ice, 1 ml of 2 M KCl solution 
was added in small portions with gentle swirling. A white precipitate 
of potassium dodecyl sulfate and protein appeared. The mixture was 
then poured into a polyallomer centrifuge tube and centrifuged at 
0 27,000 g and 4 C for fifteen minutes in the Beckman/Spinco ModelL 
ultracentrifuge using the swinging bucket rotor Sl-1 36 (at 16,000 rpm). 
The supernatant containing the T2 DNA was decanted into a conical 
stoppered glass centrifuge tube and the pellet was discarded. 6.5 m1 
' . 
•· 
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of freshly distilled phenol (collected between 176 and 178 °C) con-
taining 0.08 % of 8-hydroxy-quinoline and saturated with 0.1 M sodium 
phosphate buffer, pH 7.2 was added to the supernatant and the mixture 
was rocked for 30 minutes at room temperature with a frequency of about 
40 cycles/minute. After centrifugation in the International Model PR-2 
Portable Refrigerated Centrifuge using head No. 296 at 2,000 rpm and 
4 °C, the top aquaeous phase was transferred into a polyallomer centri-
fuge tube and was further centrifuged at 27,000 g for 30 minutes as 
described above. The supernatant was decanted and dialyzed against 1 
liter of 0.01 M Tris-HCl buffer, pH 7.3, containing 0.01 M KCl and 
0.5 mM EDTA. 0 The dialyzis was performed at 4 C for four days with 
daily changes of the buffer. The resulting T2 DNA solution was stored 
at 4 °C. 
' 
0 This DNA preparation had a melting temperature of 86 C and 
46 % hyperchromicity at 260 nm in 0.08 M Tris-HCl buffer, pH 7.0, con-
taining 0.4 M KCl and 0.02 M Mgcl2 • The A260!Az80 ratio was 1.75, 
indicating low protein contamination (Thomas and Abelson, 1966). 
T2 DNA concentrations were determined spectrophotometrically 
using an extinction coefficient of 6500 at 260 nm (Mahler et al., 1964) 
and a mean residue weight of 357 daltons (Rubinstein et al., 1961). 
II.5. Preparation of Stock and Working Solutions 
Calf thymus DNA was dissolved (3-4 mg/ml) in 0.01 M sodium 
0 
chloride solution with slow stirring at 4 C for 48 hours. The so-
lution was then dialyzed twice, each time against 40 volumes of 0.01 M 
sodium chloride solution for 24 hours at 4 °C. The resulting DEA stock 
0 
solution was stored at 4 C. 
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Before each experiment, a working DNA solution was·prepared by 
diluting the DNA stock solution with the appropriate buffer. The 
concentration of DNA was determined spectrophotometrically using a 
r molar extinction coefficient of 6600 liter/cm/N:ole of DNA phosphorous 
(Mahler et al., 1964) or a specific extinction coefficient of 20 liter/ 
cm/g of DNA (Nakamoto et al., 1964). 
Working solutions of Miracil D, methyl-Miracil D, and MDMT were 
prepared by dissolving these compounds in buffer. For this purpose, 
the purified Miracil D preparation (see section II.3) was used, while 
both methyl-Miracil D and MDHT were used as supplied (see section II.1). 
Drug concentrations were determined spectrophotometrically using the 
i i d 1 ' ' ff' . ' 1' M 1 - 1 - 1 follow ng est mate mo ar ext~nct~on coe ~c~ents ~n ~ter• o e •em : 
Miracil D 8040 at 330 nm 
Methyl-Miracil D 3600 at 425 nm 
MDI-IT 3900 at 302 nm 
These molar extinction coefficients in buffer were calculated on the 
basis of the weighed amounts (about 10 mg) and the molecular weights of 
the compounds specified by the suppliers (see section II.1). 
Unlabeled nucleoside triphosphate solutions were prepared simply 
by dissolving the salts in deionized water (total volume not more than 
1 ml). The solutions (pH 4) were titrated with 50% sodium hydroxide 
solution to pH 7.0 using 1 ~1 chromatographic applicators. 
Radioactively labeled nucleoside triphosphate solutions were 
prepared by dissolving the solid commercial preparations in unlabeled 
nucleoside triphosphate solutions. l~enever these preparations were in 
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liquid form, they were placed in an ice bath and dried under a stream 
of nitrogen. 
11.6. Preparation of Drug-DNA Complexes 
Drug-DNA complexes were prepared from working solutions (see 
section 11.5) of the drugs and DNA. Since the drug solutions have a 
tendency to be retained on the inner surfaces of glass pipettes used 
for transfer, a specific procedure was used for the preparation of the 
complexes to insure greater accuracy. Since in the binding studies and 
circular dichroism measurements the drug concentration was maintained 
-5 
constant at 2xl0 M and the DNA concentration was varied as appropri-
ate, typically, 5 g of drug solution was weighed into a 25 ml volumet-
ric flask followed by the addition of the required volume of DNA work-
ing solution, and filled up with buffer to volume. 
II.7. Dimerization Studies 
Solutions for these studies were prepared from working solution 
of Miracil D by weighing a given amount and diluting it with buffer to 
the required final volume. The concentration ct of the drug in these 
solutions and the path length 1 of the spectrophotometric cells were 
selected so that the product ct•l was identical for each sample. This 
method permits isosbestic points to be located by visual inspection of 
the resulting spectra. 
Absorption spectra of drug solutions in the near ultraviolet 
wavelength region were recorded at room temperature. Because of the 
tendency of the drug to be absorbed to the surfaces of the glassware, 
spectra were recorded immediately following the preparation of the 
solutions. Scanning rates were about 1.6 ~/sec, the slowest possible 
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in order to insure the most accurate recorder pen response. Both rec-
' tangular and cylindrical fused silica cells of different pathlengths 
were used. 
For the determination of the dimerization constant, the method 
of Lamm and Neville (Lamm and Neville, 1965) was utilized. This method 
is based on the following principle. In a solution containing the 
monomeric and dimeric forms of a compound, the laws of mass conservation 
and mass action can be stated as 
and 
where c's are the molar concentrations, the subscripts m and d refer to 
monomer and dimer, respectively, and Kd is the dimerization constant. 
From the law of mass action, the dimer concentration cd can be expressed 
2 
as cd=Kd·~ • Substitution for cd in the law of mass conservation 
2 yields the relationship 2•Kd·cm+cm-ct=O , which is quadratic in the 
monomer drug concentration em • Using the general solution formula of 
quadratic equations gives 
Defining a as the fraction of drug present as monomer by a=cm/ct, 
a can be expressed as a function of ct and Kd: 
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V1+8·K •C -1 
- d t a--------------- (1) 
4-Kd.ct 
If the monomer and the dimer are the only two absorbing species, 
the absorbance A of the solution can be expressed as the sum of contri-
butions from the monomer and dimer: 
A=E •C ·l+E •C ·1 , 
m m d d 
where Em and Ed are the molar extinction coefficients of the monomer 
and dimer, respectively. By defining the apparent molar extinction 
coefficient E of a solution as E =A/(c ·1), it follows that 
app app t 
E =(E -Ed/2)·a+Ed/2 • app m (2) 
This indicates that the apparent molar extinction coefficient is a 
linear function of a, and the slope and the intercept of theE 
. app 
versus a line are determined by the molar extinction coefficients of 
the monomer and dimer. 
The linear property of equation (2) was used in the determi-
nation of the dimerization constant. First, arbitrary values were 
assigned to Kd and the fraction a of drug present as monomer was calcu-
lated according to equation (1) for each sample and each Kd. Using 
these a values and the corresponding apparent extinction coefficients, 
which were obtained experimentally, the best straight line fit to 
equation (2) was calculated by the method of non-weighted least-
squares. The procedure was repeated with different values of Kd until 
a minimum was reached in the root-mean-square deviation between the 
45 
experimentally obtained apparent molar extinction coefficients and the 
computed best straight line values. The Kd is the dimerization 
constant of the drug most compatible with the experimental results. 
For the Kd value that gives the minimal root-mean-square devi-
~ ation, the slope and the intercept of the best fitting straight line 
can be used to determine the monomer and dimer molar extinction coef-
ficients. 
11.8. Binding Studies 
The binding of thioxanthenones to nucleic acids was investigated 
by the spectrophotometric method of Peacocke and Skerrett (Peacocke and 
Skerrett, 1956). The method utilizes, as a binding parameter, the 
change in the absorption spectrum of the ligand as it binds to the 
nucleic acids. 
The absorption spectra of drug-nucleic acid complexes were re-
corded in the visible and near ultraviolet wavelength regions. A 
buffered solution of DNA with a concentration equal to that present in 
each drug-DNA complex was employed as reference. For these measure-
ments, fused silica cells of 5 and 10 em pathlengths were used. The 
procedures described for the dimerization studies (see section !!.7) 
were used for recording the spectra. 
!!.8.1. The Analysis of the Spectra of Drug-Nucleic Acid Complexes 
The method of Peacocke and Skerrett was also used for the a-
nalysis of the spectra. A brief description of this method is pre-
sented below. 
For a mixture of free and bound ligands in the presence of 
nucleic acids, Beer's law and the law of mass conservation can be 
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stated as 
and 
~here A, E's, c's and 1 are the absorbance, the molar extinction coef-
ficients, the molar concentrations, and the pathlength, respectively. 
The subscripts t, f, and b refer to the total, free, and bound ligands, 
respectively. It is assumed that both the free and bound ligands them-
selves obey Beer's law and that the DNA does not absorb light at the 
wavelength selected for the study. Any deviation from the principle of 
additivity is considered as evidence for the presence of more than one 
kind of species of free or boun4 ligands. 
The absorbance of the mixture of free and bound ligands can be 
expressed from these equations as 
If a wavelength can be found for which Ef=Eb, then A=Ef•ct•l, which 
means that the absorbance of the mixture is independent of its compo-
sition. This wavelength is called the isosbestic wavelength. 
In practice, a series of solutions are prepared with identical 
ligand concentrations and varying nucleic acid concentrations. If an 
isosbestic wavelength is present then the spectra of all complexes 
cross through a single point (isosbestic point) at the isosbestic wave-
length. The existence of an isosbestic point is a good indication of 
the presence of only two kinds of absorbing species. Obviously, the 
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lack of an isosbestic point does not preclude the possibility that only 
two kinds of absorbing species are present. 
For the absorbance Af of the solution which does not contain 
bound ligand, we have 
A =E •c •1 f f t , 
and for the absorbance Ab of the solution which does not contain free 
ligand, we have 
A_ =E •c •1 
l> b t 
By combining these relationships, the concentration of bound ligand 
can be calculated according to the equation 
A -A f 
c =-------•c 
b A -A t 
f b 
To improve the accuracy of the determination of cb, a wavelength is se-
lected for the measurements which maximizes the value of Af-~· 
II.8.2. The Determination of the Absorption of Bound Drug 
In general, the value of Ab is not available experimentally. 
For its determination, the method of Crothers (Crothers, 1974) was 
used with some modifications. According to this method, at extremely 
high nucleic acid concentrations [P], the double reciprocal relation-
ship 
1 1 1 1 
------=-------+-------------------·---
A -A f 
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where K and Ba are the apparent binding constant and· the apparent app pp 
number of binding sites, respectively, can be used to obtain the value 
of the absorption Ab of bound drug. This is possible because the plot 
of the reciprocal differential absorbance 1/(Af-A) versus the recipro-
cal nucleic acid concentration 1/[P] should yield a straight line with 
an intercept of 1/(Af-Ab). Since at low nucleic acid concentrations 
deviations from linearity are known to occur (Hayman, 1962), a poly-
nomial rather than linear extrapolation was used to obtain the value 
of the intercept. The calculations were performed using the computer 
program POLFIT available from the Public Library of the Computer Center 
at Loyola University of Chicago. 
II.8.3. Scatchard Plots and Their Interpretation 
For the presentation of the results of binding studies, the 
method of Scatchard was chosen (Scatchard, 1949). Plots of r/cf 
versus r were prepared, where the binding ratio r is defined by 
cb 
r=---- • (3) 
(P] 
The values of r/cf and r were calculated directly from absorbance 
measurements using the equations 
r 1 
----=------·---
and 
Af-A ct 
r=-------·---- . 
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The binding of thioxanthenones to nucleic acids was interpreted 
on the basis of the exclusion model for binding (McGhee and von Rippel, 
f. 1974). According to this model, if the binding of ligands to nearest 
• 
neighbour sites of nucleic acids is not allowed, then the binding iso-
therm may be described by the equation 
r (l-4•r) 2 
----=K·---------- (4) 
cf 2• (1-2·r) 
~ 
R where K is the .intrinsic association constant between the ligand and 
the nucleic acid. 
The intercepts of the isotherm with the r and r/cf axes must 
~' be located at r=0.25 and r/cf=K/2, respectively, and the isotherm must 
always fall below the line determined by these intercepts. The 
curvature of the isotherm is most pronounced in the region of 0.125 < 
r < 0.25. 
\. The fitting of the exclusion model to the experimental data was 
performed using the computer program described in Appendix B. In this 
procedure, arbitrary values were given to K and the theoretical binding 
isotherms were calculated. The K which produced an isotherm which fit 
the experimental points within experimental error was assumed to be the 
true intrinsic association constant. A maximum error of 0.003 in ab-
sorbance and an error of 1.5 % in nucleic acid concentration was as-
sumed throughout all calculations. 
II.9. Circular Dichroism Measurements 
Circular dichroism measurements were carried out on the Jasco 
Model ORD/UV-5 Optical Rotatory Dispersion Recorder. The instrument 
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was calibrated with an 0.1 % aquaeous solution of d-10-camphorsulfonic 
acid (supplied by Durrum Instruments Corporation, Palo Alto, California 
94303). This standard solution placed in a 1 em spectrophotometric 
cell gives an ellipticity of +0.313 degrees at 290 nm, corresponding to 
J. 
a pen deflection of 15.65 em on the 0.02 degrees/em scale of the 
spectropolarimeter. 
The circular dichroism spectra of drug-DNA complexes were re-
corded in 5 and 10 em cylindrical fused silica cells at room temper-
ature. The absorbance of the samples was always maintained below 2.0 
in order to avoid artifacts in optical activity. 
f The results of circular dichroism measurements are reported 
~ ~ either as differential molar extinction coefficients EL-ER or differ-
~ 
f; ~ entia! absorbance AL-AR. They were calculated using equations 
' f 
and 
0 
t\. -A =----
• L R 33 
0 
EL-ER=-------- , 
33•c•l 
(5) 
where the ellipticity 0 (in degrees) was read directly from the chart 
paper, 1 is the pathlength in em, and c is the molar concentration of 
species responsible for the circular dichroism. Therefore, the values 
of AL-AR and EL-ER were obtained in units of absorbance and liter• 
-1 -1 Mole •em , respectively. 
~.· ~·· 
t 
~ ! 
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1].10. Measurements at Elevated Temperatures 
1].10.1. Definitions, Terminology, and Formulas Used in Hyper-
£Promicity Measurements 
Hyperchromicity his defined (Mahler et al., 1964) by thee-
quation 
At 
h=----- -1 ' 
At 
0 
where At and At are the absorbances of a hyperchromic substance at a 
0 
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given wavelength, temperature t, and reference temperature t • There-
o 
fore, hyperchromicity measurements are carried out by the measurement 
of absorbance as a function of temperature. The instrumentation used 
for these studies is described in the next section. 
A typical set of hyperchromicity versus temperature plots (also 
referred to as melting curves or melting profiles) of nucleic acids and 
drug-nucleic acid complexes are shown in Figure 8. It can be seen that 
the hyperchromicity increases, reaching a maximum plateau, with in-
creasing temperature. If the maximum hyperchromicity value reached is 
denoted by h, the melting temperature Tm is defined as the temperature 
at which 50 % of the maximum hyperchromicity is attained (Mahler et 
al., 1964), that is 
h(T )=0.5•h . 
m 
This classical definition is readily applicable for melting curves 
representing a single cooperative transition restricted to a relatively 
narrow temperature range (Figure 8, curve a). For cases where the 
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Figure 8. Typical dependence of hyperchromicity h on the temperature 
of nucleic acids and drug-nucleic acid complexes (see text for details). il 
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transition is more complex and it takes place in a relatively wide 
temperature range, a modified melting temperature T~ is defined (Gersch 
and Jordan, 1965). According to this new definition, T~ is the temper-
ature at which 50 % of the maximum hyperchromicity is attained from 
the onset of the rapid increase to the maximum of hyperchromicity. The 
intercept of the extrapolated linear segments of the melting curves 
determines the onset of the rapid increase (Figure 8, curve b). In 
the present investigation both the classical and modified definitions 
for melting temperatures are used. Reference to the appropriate 
melting curve indicates which definition is applicable in each instance. 
In the presentation of the present experimental results, the normalized 
hyperchromicity hn will be used, which is defined by the equation 
h 
hn=-=- • 
h 
Since melting temperatures are invariant to this linear transformation, 
they can be determined directly from the normalized hyperchromicity 
versus temperature plots. 
0 In the present studies, the reference temperature is 25 C, and 
0 
the maximum hyperchromicity is obtained at 98 C, i.e. 
- A9s 
h=h(98)=----- -1 , 
A25 
so the normalized hyperchromicity hn at temperature t was calculated 
using the equation 
(6a) 
Measurements of absorbance as a function of temperature were 
also carried out at wavelengths where the nucleic acids do not absorb 
light (i.e. 440 nm). The changes of absorbance at these wavelengths 
are the result of drug dissociation from the drug-nucleic acid 
complexes. For the quantitative treatment of drug release from the 
complexes, the normalized absorbance change ~A is used, which is 
n 
calculated using the equation 
~A 
n 
=~~=~£2_ (6b) 
A98-A25 
For the normalized absorbance change ~A versus temperature profiles, 
n 
the concept of dissociation transition temperature of drug-DNA 
complexes, corresponding to the melting temperature T of melting 
m 
profiles, can be introduced. The dissociation transition temperature 
of drug-DNA complexes is the temperature at which 50 % of the maximum 
normalized absorbance change is attained. At this temperature, 50 % 
of the drug bound at the reference temperature (i.e. at 25 °C) is re-
leased from the complex. 
!!.10.2. Instrumentation 
The dependence of absorbance and circular dichroism on temper-
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ature was studied by the simultaneous recording of absorbance or circu-
lar dichroism and temperature of drug-DNA complexes. 
Solutions were placed in a special heated cell holder assembly 
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(~ modified part of the Beckman TM Analyzer) , which can be fitted with-
in the sample compartments of the Cary Model 15 Recording Spectropho-
tometer or the Jasco Model ORD/UV-5 Spectropolarimeter. The tempera-
ture of the cell holder assembly can be linearly increased at a 
programmed rate by means of the Beckman TM Analyzer. The. rate used was 
3 °c/minute. The sample temperature was measured, using the Beckman 
Temperature Bridge, which monitors the temperature of distilled water 
in a cell adjacent to the sample cell within the cell holder assembly. 
The Analyzer produces an electrical signal (between 0 and 10 mV) , 
proportional to the temperature of the sample. Potentiometers installed 
on the pen drive shafts of the spectrophotometer and spectropolarimeter 
produce resistances (between 0 and 10 kQ) , proportional to the ab-
sorbance or the circular dichroism of the sample under examination. 
The potentiometers are connected through a custom-made calibration box 
to the Y-axis input of the Moseley Model 7035B X-Y Recorder (Martz and 
Aktipis, 1971). The calibration box serves two purposes. One is to 
transform the resistances of the potentiometers to electrical signals 
and the other to provide for expansion and baseline adjustments of the 
electrical signal. The signal from the Beckman Temperature Bridge is 
directly _applied to the X-axis input of the recorder. With this instru-
ment assembly it is possible to obtain directly the absorbance or circu-
lar dichroism as the function of temperature. 
11.10.3. Determination of the Dependence of Association Constants 
on Temperature 
The dependence of the intrinsic association constant K for the 
binding between drug and nucleic acid on the temperature can be de-
'· 
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termined by combining the results of binding studies at room tempera-
ture with the results of absorbance measurements at 440 nm as the 
function of temperature. Since the increase of absorbance at 440 nm is 
the result of drug release from the drug-DNA complexes, therefore, 
hA (t) denotes the fraction of the drug which is bound at 25 °c, but 
n 
which is released at temperature t, i.e. 
~(25)-cb(t) 
hA (t)=-------------- , 
n ~(25) 
from which 
(7) 
Dividing by the nucleic acid concentration [P] and using the definition 
of the binding ratio r, we obtain 
r(t)=r(25)•[1-hAn(t)] . (8) 
In this formulation it is assumed that both the free and bound drug 
extinction coefficients are independent of temperature or that if these 
coefficients depend on it, their dependence is small and such that e-
quation (8) is still obeyed. From equations (3) and (4), the intrinsic 
association constant K can be expressed as 
2•r•(l-2•r) 
K=--------2------------ . 
(1-4•r) •(c -r·[P]) t 
(9) 
From the known values of the normalized absorbance changes at 
temperature t and of the intrinsic association constant K at room 
temperature, the intrinsic association constant K at temperature t can 
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be calculated using equations (8) and (9). The results of these calcu-
lations are reported as log10K versus 1/T (van't Hoff plots), where T 
h b 1 t t t Th lt • 1 • 1 -AH0 / is t e a so u e empera ure. e resu 1ng s ope 1s equa to u 
0 (2.303•R), where flH and Rare the standard enthalpy change and the gas 
constant, respectively. The standard enthalpy change 6H0 can be calcu-
lated from the slope of the van't Hoff plots. The standard free ener-
gy change 6G0 and the standard entropy change 6S0 can be calculated 
using the equations 
6G0 =-R•T•lnK 
and 
(Klotz and Rosenberg, 1972). 
11.10.4. Measurements of the Circular Dichroism of Drug-DNA Complexes 
at Elevated Temperatures 
Investigations of the dependence of circular dichroism on the 
temperature were performed with instrumentation similar to that used in 
hyperchromicity measurements except that the spectrophotometer was re-
placed by the spectropolarimeter (see section 11.10.2). The dependence 
of the differential molar extinction coefficient on the temperature was 
calculated in the following way. From equations (3) and (7) (see 
sections 11.8.3 and 11.10.3, respectively), the bound drug concen-
tration cb(t) at temperature t can be expressed as 
where r(25) is the binding ratio at 25 °C, [p] is the nucleic acid 
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concentration, and ~A (t) is the normalized absorbance change at temper-
n 
ature t. Using the equation for ~A (t) (equation (6b), section 
n 
11.10.1), we have 
cb(t)=r(25)·[P]· {1- At-A25 
---------} . 
A98-A25 
Substitution of this expression into equation (5) (see section 11.9) 
gives 
0 t (Et-ER)t=--------------------------------------- • 
33•l•r(25)•[P]•{1-(A -A )/(A -A )l t 25 98 25 
The differential molar extinction coefficient (EL-~)t at temperature t 
was calculated according to this equation, where the ellipticity et at 
temperature t was directly read from the recorder chart paper (see 
section 11.10.2), the path length 1 was 1 em in each instance, and the 
absorbances A25 , A98 , and At at 440 nm (see section 11.10.3 as well) 
were directly read from the recorder chart paper (see section 11.10.2). 
11.11. RNA Polymerase Assays 
DNA dependent RNA polymerase activity was determined by the 
method of Richardson (Richardson, 1973) with minor modifications. In 
this method the enzymatic activity is determined by measuring the in-
corporation of radioactively labeled nucleoside triphosphates into 
ribonucleic acid insoluble in 5 % trichloracetic acid. 
Assay mixtures were prepared with Hamilton syringes in 10x75 mm 
disposable glass test tubes. The test tubes and all glassware were 
0 . 
preheated at 180 C for at least 48 hours before use in order to in-
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activate any possible nuclease contamination (Sreevalsan; 1973). Dis-
posable plastic gloves were worn in the course of this work to prevent 
any contamination by skin nucleases. 
The three major components of an assay mixture, i.e.: DNA de-
pendent RNA polymerase (the enzyme), DNA (the template) with or with-
out inhibitor, and the four nucleoside triphosphates NTP (the 
substrates) were dissolved in 0.1 ml of buffered solution with the 
following composition: 
0.04 M Tris-HCl, pH 7.0 at 25 °C 
0.2 M KCl 
0.01 H MgC12 
0.1 mM EDTA 
0.1 mM dithiothreitol 
0.4 mg/ml bovine serum albumin 
A solution with the same composition but in which the concentrations 
of the components are 2.5 times higher will be referred to as buffer A. 
In these experiments, the template solution with or without in-
hibitor was prepared in a total volume of 45 lll in an ice bath from 
deionized water, DNA stock solution (see section II.S) and an unbuffered 
solution of the inhibitor. The latter solution was titrated to pH 5.0 
before use, in order to prevent the precipitation of DNA by the in-
hibitors. After the addition of 37 lll ice-cold buffer A to the template 
solution, the enzyme was added in 3 lll of an ice-cold solution con-
sisting of commercial enzyme solution, deionized water, and 3 lll of 
buffer A. 0 The mixture was transferred to a 37 C water bath and was 
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incubated for 6 minutes. The reaction was then initiated"by the rapid 
addition (using Hamilton syringe) of 10 lll of a solution consisting of 
ATP, CTP, GTP, and 8-[ 3H]-UTP (specific activity: 4.99 counts/minute/ 
pMole of UTP) at a concentration of 5~~ each (i.e. ten times the final 
concentration) in deionized water, pH 7.0. The reaction was allowed to 
proceed for 8 minutes at 37 °C, and it was terminated by the addition 
of 1 ml of freshly prepared ice-cold 5 % trichloracetic acid solution 
containing 0.05 M sodium pyrophosphate. 
After thorough vortexing and standing in ice for at least 20 
minutes, but not longer than 90 minutes, the insoluble material was 
collected by filtration through Whatman GF/C filter disks (2.4 em in 
diameter). The precipitate on the disks was rinsed with 20 ml of ice~ 
cold 5 % trichloracetic acid solution containing 0.05 M sodium pyro-
phosphate. The precipitate was further washed with 30 ml of ice-cold 
95 % ethanol and then dried under vacuum overnight. 
The radioactivity retained on the disks was counted after ad-
clition of 10 ml of 0.4 % 2,5-diphenyloxazol solution in toluene. 
The radioactivity absorbed and retained by the filter disks 
themselves and the radioactivity trapped within the precipitated com-
portents of the assay mixtures was determined from the residual radio-
activity of blanks which did not contain any enzyme. 
The specific activities of nucleoside triphosphate solutions 
were determined from measurements carried out using 10 lll aliquots of 
these solutions. These aliquots were placed on filter disks, dried 
under vacuum overnight, and then counted as described above. 
Experiments, in which the template concentration or the reaction 
62 f ~' d f d b . t: time were varie , were per orme in the a sence of inhibitors. The 
same experimental procedure described above was used with the exception 
that in the case of experiments in which the reaction time was varied, 
0.1 ml aliquots were removed at different times from a master ~ssay 
mixture (1.2 ml) and dispensed into 1 ml of ice-cold 5 % trichloracetic 
acid solution containing 0.05 M sodium pyrophosphate. The mixture was 
filtered and dried as described above. 
Experiments designed to measure the inhibition of ribonucleic 
acid chain initiation were conducted as described above except that a 
nucleoside triphosphate solution consisting of y-[ 32P]-ATP, CTP, GTP, 
and 8-[ 3H]-UTP (specific activities: 2200 cpm/pMole of ATP and 27 cpm/ 
pMole of UTP, respectively) at a concentration of 2.5 mM for each 
nucleoside triphosphate (ten times the final concentration) in deionized 
water, pH 7.0 was used. In these experiments 7 minutes preincubation 
and 7 minutes incubation were employed. 
Special procedures for terminating the reaction and for washing 
32 
were used for the experiments involving P incorporation, so as to 
reduce the high background due to unincorporated radioactivity, which 
were noted. Reactions were terminated by the addition of 0.5 ml ice-
cold 0.1 M sodium pyrophosphate solution containing 20 mM ATP and 2 mM 
UTP and 0.5 ml of ice-cold 10 % trichloracetic acid solution containing 
1 M KCl. The insoluble material collected on the filter disks was 
soaked in 50 ml of ice-cold 5 % trichloracetic acid solution containing 
1 H KCl and 0.01 M sodium pyrophosphate for 1 hour, and further soaked 
in 40 ml of ice-cold 95 % ethanol for 20 minutes. The filter disks 
were dried as before and placed in 10 ml of 0.4 % 2,5-diphenyloxazole 
r· olution in toluene for counting the radioactivity. 
1.: s 
t 3 32 Simultaneous counting of H and P activities were performed 
in the Beckman Model LS-250 Liquid Scintillation System using the 3H 
below 14c and 32P above 3H Isosets at a gain setting of 310. Under 
these counting conditions less than 2 % activity spill-over between 
3H and 32P could be detected. 
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CHAPTER III 
EXPERit1ENTAL RESULTS 
III.l. Dimerization Studies 
The ultraviolet spectra of Miracil D in 0.01 M sodium acetate 
buffer, pH 5.0 over a 50-fold concentration range are shown in Figure 9. 
In dilute solutions, the absorption maximum is at 330 nm with a shoulder 
around 350 nm. As the concentration is increased, the shoulder becomes 
more pronounced and the absorption peak decreases in intensity and 
shifts to longer wavelengths. As it can be seen in Figure 9, Miracil D 
does not obey Beer's law. The existence of isosbestic points at 303.5 
and 352 nm indicates that two spectral species are present over the 
-3 -5 
concentration range of 10 to 2xl0 M. 
For the determination of the dimerization constant Kd, the method 
of Lamm and Neville (Lamm and Neville, 1965) was used (see section 
II.7). In the calculations, absorbances of Miracil D solutions in the 
range between 315 and 350 nm at 2.5 nm intervals (a total of 15 wave-
lengths) were used. The root-mean-square (RMS) deviation in absorbance 
units as the function of the dimerization constant Kd is shown in 
Figure 10. -1 The minimum value of the RMS deviation is at Kd=406 ~ and 
this value is assumed to be the dimerization constant of Miracil D in 
0.01 M sodium acetate buffer, pH 5.0. At its minimum, the ~MS deviation 
is only 0.002 which is within the limits of the error specifications of 
the spectrophotometer used. 
According to equation (2) (see section II.7), the apparent ex-
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Figure 9. The absorption spectrum of Miracil D in 0.01 M sodium ace-
tate buffer, pH 5.0 at room temperature. Miracil D concentrations: 
-5 4 (a) 2x10 M in 5 em cell, (b) 5x10- M in 0.2 em cell, and (c) 
in 0.1 em cell. 
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Figure 10. The dependenc_e of the root-mean-square (RMS) deviation (in 
units of absorbance) on the dimerization constant Kd of Miracil D at 
room temperature. A minimum is observed at K =406 M-1• 
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tinction coefficient Eapp is a linear function of the fraction a, of 
drug present as monomer. To illustrate the precision of the fit with 
-1 
K =406 M , the apparent extinction coefficient E of Miracil D so-d - app 
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lutions as a function of a, at 315, 320, 325, and 330 nm is presented in 
Figure 11. The straight lines calculated on the basis of equation (2) 
and a Kd value of 406 M- 1 , are the best fitting lines to the experi-
mentally obtained apparent extinction coefficients. 
The dimerization of Miracil D was also investigated in 0.2 M 
sodium acetate.buffer, pH 5.0 at room temperature. A value for the 
-1 dimerization constant Kd of 410 M was obtained, indicating that the 
dimerization is practically independent of ionic strength in the ionic 
strength range studied. 
Since the pK 's for Miracil D are -0.20 and 7.4, in aquaeous 
a 
solutions at pH 5.0 the drug is present as a positively charged ion 
with a single charge localized on the distal nitrogen atom. Therefore, 
the present dimerization studies describe an equilibrium between the 
singly charged monomeric and doubly charged dimeric forms of the drug. 
III.2. Binding Studies 
!11.2.1. The Binding of Miracil D to Calf Thymus DNA at 0.01 and 
0.2 M Salt Concentrations 
The binding of Miracil D to calf thymus DNA was investigated in 
0.01 M sodium acetate buffer, pH 5.0 at room temperature. In these 
measurements, the concentration of Miracil D was maintained constant 
-5 at 2x10 M, while the DNA concentration was varied. The absorption 
spectra of Miracil D-DNA complexes are shown in Figure 12. 
Free Miracil D exhibits an absorption maximum at 330 nm with 
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Figure 11. The dependence of the apparent extinction coefficient 
E on the fraction a of Miracil D present as monomer at various 
app 
wavelengths as indicated in the figure. The straight lines are calcu-
-1 lated with Kd=406 M • 
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Figure 12. The absorption spectra of ~liracil D-DNA complexes in 0.01 M 
sodium acetate buffer, pH 5.0 at room temperature obtained in 5 em 
cells. -5 Miracil D concentration: 2x10 M, DNA concentrations: (a) 0, 
-6 -5 -4 (b) 8.4x10 M, (c) 5x10 M, and (d) 3.4x10 ~-
73 
300 320 340 360 
Wavelength, nm 
74 
8 slight shoulder centered around 352 nm. Upon addition of DNA, the 
intensity of the maximum decreases, the maximum shifts to longer wave-
· lengths, and the shoulder becomes a little more pronounced. ~ ~ At the f. highest DNA concentration (3.4xl0 M), the maximum shifts to 337 nm • 
.. 
QUalitatively similar spectral changes were observed for the inter-
action of other intercalating drugs, such as ethidium bromide (Waring, 
1965), proflavine (Dourlent and Helene, 1971), and acriflavine (Tubbs 
et al., 1964) with nucleic acids. The existence of three isosbestic 
points at 304, 352, and 364 nm indicates that only two spectral species 
are present. The largest changes of absorbance were obtained at 325 nm 
and, therefore, absorbances at this wavelength were used in calculating 
the binding parameters. 
Since the value of the absorbance of the bound drug, ~· is not 
generally obtainable experimentally, it was determined from the plot of 
the reciprocal differential absorbance 1/(Af-A) versus the reciprocal 
nucleic acid concentration 1/[p] (see section II.8.2), which is pre-
sented in Figure 13. As it can be seen, the plot is not linear in the 
experimentally available nucleic acid concentration region, and, 
therefore, a standard polynomial curve fitting procedure was used to 
obtain the intercept of the best fitting polynomial (solid line) with 
the ordinate. 
The Scatchard plot of the binding of Miracil D to calf thymus 
DNA in 0.01 M sodium acetate buffer, pH 5.0 at room temperature is 
shown in Figure 14. The experimental points are shown together with 
the calculated theoretical isotherm obtained using an intrinsic associ-
6 -1 
ation constant of 1.2x10 M • The isotherm describes the binding of 
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Figure 13. A plot of reciprocal differential absorbance 1/(Af-A) 
reciprocal DNA concentration 1/[P] for determining the absorbance Ab of 
bound drug (see text for details). 
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Figure 14. The Scatchard plot of the binding of Miracil D to calf '~ £1 
temperature. j thymus DNA in 0.01 M sodium acetate buffer, pH 5.0 at room 
The experimentally obtained points are shown together with the calcu-
lated isotherm (solid line) for an intrinsic association constant of 
6 -1 1.2x10 M • 
j 
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Miracil D to calf thymus DNA on the basis of the exclusion model. In 
this model, it is assumed that the binding of one Miracil D molecule to 
DNA prevents the binding of other Miracil D molecules to the nearest 
neighbour binding sites. The validity of this assumption will be 
discussed in section IV.2. The calculations were performed as out-
lined in section II.7. 
The binding of Miracil D to calf thymus DNA was also investi-
gated in 0.2 M sodium acetate buffer, pH 5.0 under identical experi-
mental conditions. For this case, the Scatchard plot and the calcu-
lated theoretical isotherm determined by an intrinsic association 
4 -1 
constant of 4.5x10 M are shown in Figure 15. 
-5 At Miracil D concentrations of 2x10 M more than 98 % of the 
drug is present as a monomer with a single positive charge (Kd's of 
-1 -1 406 M in 0.01 M sodium acetate buffer, pH 5.0 and 410 M in 0.2 M 
sodium acetate buffer, pH 5.0 were used for these calculations; see 
section III.l). Therefore, the spectral changes observed in the 
binding studies are the result of an equilibrium between the singly 
charged monomeric form of Miracil D and the intercalated form of the 
drug. 
It should be noted that increasing ionic strength decreases the 
extent of binding. A 27-fold decrease in the intrinsic association 
constant was observed going from 0.01 M to 0.2 M sodium acetate buffer, 
pH 5.0. This finding is in agreement with the general trend exhibited 
in the binding of other intercalators to nucleic acids (Aktipis and 
Kindelis, 1973; Blake and Pecocke, 1968; Waring, 1965). 
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Figure 15. The Scatchard plot of the binding of Miracil D to calf 
thymus DNA in 0.2 M sodium acetate buffer, pH 5.0 at room temperature. 
The experimentally obtained points are shown together with the calcu-
lated isotherm (solid line) for an intrinsic association constant of 
4 -1 4.5x10 M • 
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III. 2. 2. The Binding of Miracil D to Calf Thymus DNA under RNA 
-
polymerase Assay Conditions 
-
The binding of Miracil D to calf thymus DNA was also investi-
gated under the experimental conditions used for DNA dependent RNA 
palymerase assays. These studies were carried out at 37 °c and in 
the same buffer as the RNA polymerase assays (see section 11.11) with 
the exception that bovine serum albumin and dithiothreitol were o-
mitted. Preliminary experiments showed that this omission had no 
effect on the extent of binding. 
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The Scatchard plot and the calculated theoretical isotherm de-
termined, using an intrinsic association constant of 1.35x104 ~- 1 , are 
shown in Figure 16. Comparison of the intrinsic association constants 
under these conditions and in 0.01 ~sodium acetate buffer, pH 5.0 (see 
section 111.2.1) indicates an 88-fold decrease in the value of the 
constant. This decrease is the result of the concerted effect of 
;· changes in both the ionic strength and the temperature to adjust for 
the conditions under which these measurements were carried out. 
111.2.3. The Dependence of the Binding of Miracil D to Calf Thymus 
DNA on Temperature 
The effect of temperature changes on the binding of Miracil D 
to calf thymus DNA were obtained from the measurements of absorbance of 
Miracil D-calf thymus DNA complexes at 440 nm as the function of 
temperature according to the method outlined in section 11.10.1. The 
' intrinsic association constants were calculated as outlined in section 
f 11.10.3. ~ 
t r The plot of log 10K versus the reciprocal absolute temperature 
.. 
tt: 
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Figure 16. The Scatchard plot of the binding of Miracil D to calf 
thymus DNA under RNA polymerase assay conditions at 37 °C (see section 
II.11). The experimentally obtained points are shown together with t 
calculated isotherm (solid line) for an intrinsic association constant 
4 -1 
of 1.35x10 M • 
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. l/T for the binding of Miracil D to calf thymus DNA in 0.01 M sodium 
acetate buffer, pH 5.0 is shown in Figure 17. A linear relationship 
0 
was obtained in the temperature range of 25 to 60 c. From the slope 
(=2.35) of the plot and from the intrinsic association constant at 
0 6 -1 25 c (1.2x10 ~ ; see section III.2.1), the following thermodynamic 
0 0 quantities were calculated: ~G =-8.2 Kcal/Mole, ~H =-10.7 Kcal/Mole, 
0 
and ~S =-8.2 cal/Mole/K. These values are correct of course only to 
85 
the extent that the activty coefficients can be assumed to be at unity. 
0 . 0 Since the absolute value of ~H 1s greater than that of T·~S 
0 0 (10700 > 298·8.2), and both ~H and T·~s have the same sign, it appears 
that the unfavourable entropy change, which accompanies the binding 
process, is overcompensated by the attending enthalpy change. 
Therefore, the binding process is enthalpy-driven. 
For a comparison of the thermodynamic quantities presented above 
with those characteristic of other intercalators, the binding of 
ethidium bromide to DNA in 1 ~ NaCl may be considered. Using the ex-
o 
elusion model, Bresloff and Crothers found that ~H =-7.8 Kcal/Mole and 
0 ~S =-7.72 cal/Mole/K (Bresloff and Crothers, 1975). This binding 
process is also enthalpy-driven. 
III.2.4. The Binding of Methyl-Miracil D to Calf Thymus DNA at 0.01 ~1 
Salt Concentration 
The binding of methyl-Miracil D to calf thymus DNA was investi-
gated in 0.01 ~sodium acetate buffer, pH 5.0 at room temperature. The 
absorption spectra of methyl-Miracil D-DNA complexes in the visible 
spectral region (Figure 18) were obtained at constant drug concen-
-5 
tration (2x10 ~) as the DNA concentration was varied. 
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Figure 17. The van't Hoff plot of Miracil D-DNA binding in 0.01 M 
sodium acetate buffer, pH 5.0. 
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Figure 18. The absorption spectra of methyl-Miracil D-DNA complexes 
in 0.01 M sodium acetate buffer, pH 5.0 at room temperature obtained 
10 em cells. -5 Methyl-Miracil D concentration: 2x10 ~. DNA concen-
~ ~ ~ trations: (a) 0, (b) 5x10 M, (c) 1.2x10 M, and (d) 6.2x10 M. 
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Free methyl-Miracil D exhibits two absorption maxima at 374 and 
425 nm. Upon addition of DNA, the intensity of both maxima decreases, 
~·· and the two bands appear to merge into a single band centered around 
410 nm. The largest changes in absorbance were obtained at 370 and 
450 nm. The absorbances at these wavelengths were, therefore, used in 
calculating the intrinsic association constant for the system. 
Although no isosbestic point is observed, the absorption 
spectra were evaluated with the assumption that only two spectral 
species are present in these solutions. If there were a DNA concen-
tration range in which the spectra of complexes exhibited an isosbestic 
point while in another DNA concentration range no isosbestic point 
could be observed, this would be a clear indication of the presence of 
more than two spectral species. This is not the case; therefore, the 
assumption about the presence of only two spectral species is compati-
ble with the spectra of methyl-Miracil D-DNA complexes (Figure 18). 
This reasoning is obviously supportive but not conclusive. 
However, the assumption that only two absorbing species are 
present is further supported by the finding that the intrinsic associ-
ation constants determined from the spectral changes at 370 and 450 nm 
are in good agreement with one another as it is apparent from ex-
amining the values listed below. 
The Scatchard plot of the binding of methyl-}liracil D to calf 
thymus DNA in 0.01 l1 sodium acetate buffer, pH 5.0 is shown in Figure 
19. The experimental points obtained at 370 nm are shown together with 
the calculated theoretical isotherm determined, using an intrinsic as-
5 -1 0 
sociation constant of 1. 7x10 H • This constant corresponds to a !1G 
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Figure 19. The Scatchard plot of the binding of methyl-Miracil D to 
calf thymus DNA in 0.01 M sodium acetate buffer, pH 5.0 at room temper-
ature. The experimentally obtained points are shown together with the 
calculated isotherm (solid line) for an intrinsic association constant 
5 -1 
of 1. 7xl0 M • 
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value of -7.1 Kcal/Mole (=-R·T·ln(1.7x10 )). The isotherm describes 
93 
the binding of methyl-Miracil D to calf thymus DNA on the basis of the 
exclusion model, the applicability of which will be discussed in 
sections IV.2 and IV.3. The calculations were performed as outlined in 
section II.7. The same calculations were performed on the experimental 
data obtained at 450 nm and an intrinsic association constant of 
5 -1 . 5 -1 1.5x10 M was obtained in good agreement w1th a value of 1.7x10 M 
obtained from data at 370 nm (see above). 
It is reasonable to assume that the pK of the distal nitrogen 
a 
atom of Hiracil D is not much affected by the methyl substitution on 
the proximal nitrogen atom. Therefore, the pKa of the distal nitrogen 
atom of methyl-Miracil D should not be much different than 7.4, the 
value noted for Miracil D. In addition, since the pK of the proximal 
a 
nitrogen atom of methyl-Miracil Dis 3.41, this drug, in analogy to 
Miracil D, should carry at pH 5.0 a positive charge on its distal 
nitrogen atom. Assuming that methyl-Miracil D has a dimerization 
-5 
constant comparable to that of Miracil D, at a concentration of 2x10 M 
more than 98 % of the drug should be present as singly charged mono-
mer. Therefore, the spectral changes observed in the binding studies 
are the result of an equilibrium between the singly charged monomeric 
form of methyl-Miracil D and the intercalated form of the drug. 
An examination of the binding of methyl-Miracil D to calf thymus 
DNA under the conditions of RNA polymerase assays was also attempted. 
However, extremely large DNA concentrations are required to observe 
small spectral changes in the spectrum of methyl-Miracil D under these 
conditions. Since a meaningful association constant cannot be ob-
94 
tained by the spectrophotometric method used in these inv~stigations, 
an estimation was performed to obtain the intrinsic association 
constant which is outlined in section III.5.3. 
!1!.2.5. The Binding of MDMT to Calf Thymus DNA 
The binding of MDMT to calf thymus DNA was investigated in 0.01 
M sodium acetate buffer, pH 5.0 at room temperature. In the course of 
this investigation, difficulties were encountered in the evaluation of 
spectral data because of two reasons. First, absorbance changes oc-
curing upon addition of DNA are small even at the highest possible 
nucleic acid concentrations. Second, the maximal spectral changes 
take place in the 300 to 315 nm region. In this region, considerable 
absorbances are exhibited by DNA especially at high DNA concentrations. 
The spectra obtained cross over one another without establishing a 
well-defined isosbestic point. Although this appears to be the result 
of limitations in the accuracy with which the DNA absorbances can be 
blanked out, the possibility that more than two absorbing species are 
present in these solutions cannot be ruled out. 
In spite of the difficulties mentioned above, the intrinsic as-
sociation constant K was estimated by giving arbitrary values to the 
absorbance Ab of DNA-bound ~IDMT. The best fitting theoretical iso-
therms were then calculated using the method described in section 
U.8.3. 3 An intrinsic association constant K ranging between 5x10 and 
Sx104 M- 1 was the most compatible with the spectral data as judged by 
the standard error of estimate. Therefore, it appears that the binding 
of MDMT to calf thymus DNA in 0.01 ~sodium acetate buffer, pH 5.0 at 
room temperature is weaker than that of methyl-Miracil D under similar 
95 
conditions (see section III.2.4). 
II 3 Circular Dichroism Measurements I . . 
1JI.3.1. The Miracil D-DNA Complex 
The circular dichroism of Miracil D-calf thymus DNA complexes 
was investigated in 0.01 M sodium acetate buffer, pH 5.0 at room 
temperature. In these measurements, the concentration of Miracil D was 
maintained constant at 2x10-5 ~' while the DNA concentration was varied. 
The circular dichroism spectra of the complexes are shown in Figure 20. 
Miracil D itself is optically inactive, but clearly optical ac-
tivity is induced upon addition of DNA. The circular dichroism spectra 
in the 300 to 375 nm wavelength region are composed of two overlapping 
negative peaks with maxima near 337 and 347 nm. These maxima appear to 
correspond to the absorption maximum of the bound drug at 337 nm and to 
the shoulder noted near 352 nm (cf. Figure 12). The positive circular 
dichroism band centered near 447 nm appears to correspond to the ab-
sorption maximum of the bound drug at 450 nm. 
The dependence of the differential molar extinction coefficient 
~-ER on the binding ratio rat 337, 347, and 447 nm is shown in 
Figures 21, 22, and 23. The concentration of Miracil D bound to DNA 
was calculated on the basis of an association constant of 1.2x106 M-l 
(see section III.2.1). At all three wavelengths, the differential 
molar extinction coefficients decrease with increasing binding ratio. 
Since the circular dichroism bands with maxima near 337 and 347 nm 
partially overlap, EL-ER values at these wavelengths are calculated 
with the understanding that they are overestimated. 
The circular dichroism of Miracil D-calf thymus DNA complexes 
96 
Figure 20. The circular dichroism spectra of Miracil D-DNA complexes 
in 0.01 M sodium acetate buffer, pH 5.0 at room temperature in 10 em 
-5 
cells. Miracil D concentration: 2xl0 ~, DNA concentrations: (a) 0, 
-5 ~ ~ (b) 3x10 M, (c) 7.6x10 ~' and (d) 3xl0 M. Binding ratios: 
(b) 0.22, (c) 0.20, and (d) 0.065. 
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Figure 21. The dependence of the differential molar extinction coef-
ficient EL-ER of Miracil D-DNA complexes at 337 nm on the binding 
r in 0.01 M sodium acetate buffer, pH 5.0 at room temperature. 
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Figure 22. The dependence of the differential molar extinction coef-
ficient EL-ER of Miracil D-DNA complexes at 347 nm on the binding ratio 
r in 0.01 M sodium acetate buffer, pH 5.0 at room temperature. 
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Figure 23. The dependence of the differential molar extinction coef-
ficient EL-ER of Miracil D-DNA complexes at 447 nm on the binding 
r in 0.01 M sodium acetate buffer, pH 5.0 at room temperature. 
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~as also investigated in 0.2 M sodium acetate buffer, pH 5.0 at room 
temperature. Because of the lowered intrinsic association constant 
under these conditions relative to that in 0.01 M sodium acetate 
buffer, pH 5.0 (see section III.2.1), a range of binding ratios from 
o.05 to 0.11 was studied. The spectra obtained under these conditions 
are similar to those in Figure 20 in their overall character and in the 
location of bands. The differential molar extinction coefficient EL-ER 
at 337, 347, and 447 nm decreases with increasing binding ratios, and 
the numerical values of EL-ER are essentially the same as those of 
Miracil D-calf thymus DNA complexes in 0.01 M sodium acetate buffer, 
pH 5.0 (Figures 21, 22, and 23). 
III.3.2. The Methyl-Miracil D-DNA Complex 
The circular dichroism of methyl-Miracil D-calf thymus DNA 
complexes was investigated in 0.01 M sodium acetate buffer, pH 5.0 at 
room temperature. In these measurements, the concentration of methyl-
-5 Miracil D was maintained constant at 2x10 M, while the DNA concen-
tration was varied. The circular dichroism spectra of the complexes 
are shown in Figure 24. 
In analogy with Miracil D, methyl-Miracil D itself is optically 
inactive, but optical activity is induced upon association with DNA. 
The positive circular dichroism maximum at 405 nm appears to correspond 
to the absorption maximum of the bound drug at 410 nm (cf. Figure 18). 
The negative circular dichroism maximum at 335 nm and the shoulder at 
353 nm correspond to the barely distinguishable shoulders at 335 and 
353 nm on the long wavelength tail of the absorption spectrum of the 
bound drug. 
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Figure 24. The circular dichroism spectra of methyl-Miracil D-DNA 
complexes in 0.01 M sodium acetate buffer, pH 5.0 at room temperature 
in 10 em cells. Methyl-Miracil D concentration: 2x10-S M, DNA concen-
trations: (a) 0, (b) lxl0-4 M, (c) 4xl0-4 M. Binding ratios: (b) 0.14 
and (c) 0.048. 
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The dependence of the differential molar extinction coefficient 
~-ER on the binding ratio r at 335, 353, and 405 nm is shown in 
Figures 25, 26, and 27. The concentration of methyl-Miracil D bound to 
DNA was calculated on the basis of an association constant of 1.7x105 
M-1 (see section 111.2.4). In general, the differential molar ex-
tinction coefficients in this system are significantly lower than those 
characteristic of the Miracil D-DNA complexes, but their dependences on 
the binding ratio r are of similar character. 
III.3.3. The MDMT-DNA Complex 
The circular dichroism of MDMT-calf thymus DNA complexes was 
investigated in 0.01 M sodium acetate buffer, pH 5.0 at room tempera-
ture. As is the case with Miracil D and methyl-Miracil D, }IDMT is 
optically inactive. -5 At a drug concentration of 2x10 M and the 
highest practical nucleic acid concentration of 4x10-4 ~. no optical 
activity could be detected in the wavelength region between 300 and 600 
nm. This finding suggests that either the complex formed is optically 
inactive or that it may be formed at such low concentrations that even 
if it were active, the circular dichroism would be below the sensitivi-
ty limits of the instrumentation. 
III.4. Hyperchromicity and Circular Dichroism Measurements at Ele-
vated Temperatures 
111.4.1. Hyperchromicity of the Miracil D-DNA and Methyl-Miracil D-
DNA Complexes 
The effect of Miracil D and its methyl derivative on the sta-
bility of calf thymus DNA against heat denaturation was investigated in 
0.01 M sodium acetate buffer, pH 5.0. The melting profiles at 260 nm 
108 
Figure 25. The dependence of the differential molar extinction coef-
ficient EL-ER of methyl-Miracil D-DNA complexes at 335 nm on the 
binding ratio r in 0.01 M sodium acetate buffer, pH 5.0 at room temper-
ature. 
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Figure 26. The dependence of the differential molar extinction coef-
ficient EL-ER of methyl-Miracil D-DNA complexes at 353 nm on the 
binding ratio r in 0.01 M sodium acetate buffer, pH 5.0 at room 
ature. 
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Figure 27. The dependence of the differential molar extinction coef-
ficient EL-ER of methyl-Miracil D~DNA complexes at 405 nm on the 
binding ratio r in 0.01 M sodium acetate buffer, pH 5.0 at room temper-
ature. 
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are presented in Figures 28 and 29. The melting temperatures at 
different drug concentrations are summarized in Table I. Both drugs 
increase the melting temperature of DNA, but Miracil D is more ef-
fective in this respect than its methyl derivative when the comparison 
is made on the basis of total drug concentrations present in these so-
lutions. An interesting feature of these melting profiles is the slow 
increase in normalized hyperchromicity noted with increasing tempera-
ture prior to DNA melting. Similar behaviour was observed in the case 
of aminoacridines, and the effect was assigned to the release of drug 
from the drug-DNA complex prior to melting (Gersch and Jordan, 1965). 
Both Miracil D and its methyl derivative are reported to in-
crease the Tm of calf thymus DNA in 0.33 ~ sodium phosphate buffer, 
pH 6.8, containing 3 ~ NaCl and 0.1 mM EDTA (Hirschberg et al., 1968). 
At drug concentrations of 5x10-6 M and calf thymus DNA concentration 
-5 0 of 5.8x10 M, the increases in Tm are 13 and 3 C, respectively (the 
ratio of total drug concentration to DNA concentration is about 0.086). 
For the comparison of these reported increases in the melting tempera-
ture with our results, complexes with drug concentration of 10-5 M 
and DNA concentrations of 1.66x10-4 M were selected (the ratio of total 
drug concentration to DNA concentration is 0.06). The purpose of this 
selection was to have the ratios of total drug concentrations to DNA 
concentrations for the reported complexes and our complexes as close as 
possible. In this case Miracil D and methyl-Miracil D cause 13.5 °C 
(=71-57.5, see Table I) and 6 °C (=63.5-57.5, see Table I) increase in 
the melting temperature, respectively. While the agreement between 
the reported values and our results is excellent for Miracil D, methyl-
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Figure 28. The dependence of the normalized hyperchromicity h of calf 
n , 
thymus DNA (a) and Miracil D-calf thymus DNA complexes (b, c, and d) at 
260 nm on the temperature in 0.01 M sodium acetate buffer, pH 5.0 and 
1 em cell. DNA concentration: 1.66x10-4 M, Miracil D concentrations: 
~ ~ ~ (a) 0, (b) 1x10 M, (c) 2x10 M, and (d) 5x10 M. Binding ratios: 
(b) 0.059, (c) 0.117, and (d) 0.219. 
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Figure 29. The dependence of the normalized hyperchromicity h of n 
calf thymus DNA (a) and methyl~Miracil D-calf thymus DNA complexes 
(b and c) at 260 nm on the temperature in 0.01 M sodium acetate buffer, 
-4 pH 5.0 and 1 em cell. DNA concentration: 1.66xl0 M, methyl-Miracil D 
-5 -5 
concentrations: (a) 0, (b) 1x10 M, and (c) 5x10 M. Binding ratios: 
(b) 0.051 and (c) 0.170. 
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Table I 
The effect of Miracil D and methyl-Miracil D on the thermal 
stability of calf thymus DNA (1.66xl0-4 M) in 0.01 M sodium acetate 
buffer , pH 5 • 0. 
Profile Concentration of added drug, M 
Drug obtained 
10-5 2x10-5 5x10-5 at 0 
Miracil D 260 nm* 57.5 °C 71 °C 77 oc 84 °C 
Methyl-Miracil D 260 nm* 57.5 °C 63.5 °C 71.5 °C 
Miracil D 440 nm** 57.5 oc 74 oc 78 °C 84 oc 
Methyl-Miracil D 440 nm** 57.5 oc 63.5 °C 71.5 °C 
* Melting temperature T 
, m 
** Drug-DNA dissociation transition temperature 
119 
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Miracil D proved more effective in our study than previously reported 
(Hirschberg et al., 1968c). This increased effectiveness is under-
standable in the view of the considerations presented in the following 
section (see section III.4.3). 
Both ~Uracil D and methyl-Miracil D absorb light at 440 nm and 
the free drugs exhibit larger extinction coefficients at this wave-
length than the DNA-bound drugs. DNA does not absorb light at 440 nm. 
Therefore, changes in the absorbance at this wavelength are proportion-
al to the amount of drugs released from the drug-DNA complexes, and 
can be used to quantitate the extent of binding of drugs to DNA. A 
similar approach has been used to investigate the proflavine-DNA and 
acridine orange-DNA systems (KleinwHchter et al., 1969). 
The dependence of the normalized absorbance change AA at 440 nm 
n 
on the temperature is presented in Figures 30 and 31, and the drug-DNA 
dissociation transition temperatures are summarized in Table I. It can 
be seen from Table I that the melting temperatures and the drug-DNA 
dissociation transition temperatures do not coinc"ide for Miracil D for 
both concentrations of 10-5 and 2x1o-5 M. This is a good indication 
that Miracil D is released from the complex in the later stages of DNA 
melting. 
This observation is understandable in the view of the reinter-
calation model proposed by Lazurkin and his coworkers (Lazurkin et al., 
1970). According to this model, the least stable regions of the double 
helix of the drug-DNA complex will dissociate first causing the release 
of drug molecules from this region. This produces a decrease in the 
effective PNA concentration so that the pool of free drug molecules in-
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Figure 30. The dependence of the normalized absorbance change ~A of 
n 
Miracil D-calf thymus DNA complexes at 440 nm on the temperature in 
0.01 M sodium acetate buffer, pH 5.0 and 1 em cell. DNA concentration: 
-4 -5 -5 1.66x10 M, Miracil D concentrations: (a) 1x10 M, (b) 2x10 M, and 
(c) 5xl0-5 M. Binding ratios: (a) 0.059, (b) 0.117, and (c) 0.219. 
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Figure 31. The dependence of the normalized absorbance change ~A of 
n 
methyl-Miracil D-calf thymus DNA complexes at 440 nm on the temperature 
in 0.01 M sodium acetate buffer, pH 5.0 and 1 em cell. DNA concen-
tration: 1.66x1o-4 M, methyl-Miracil D concentrations: (a) 1x1o-5 M and 
(b) 5x1o-5 M. Binding ratios: (a) 0.051 and (b) 0.17. 
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creases beyond the free drug concentration dictated by the law of mass 
action. Therefore, drug molecules bind to those intact regions of DNA 
molecule which are not saturated with drug molecules so as to rees-
tablish the equilibrium. The overall effect is that the release of 
drug from the complex lags behind the process of the dissociation of 
the double helix, unless the DNA is completely saturated with the drug 
before the onset of melting. Similar conclusions have been drawn about 
the ethidium bromide-DNA complex (Aktipis et al., 1975). 
The effect of ionic strength on the stabilization of calf thymus 
DNA against heat denaturation by Miracil D and methyl-Miracil D was 
investigated in 0.01 ~sodium acetate buffer, pH 5.0, containing 
0.075 M NaCl. The melting temperature of DNA under this condition is 
found to be 81 °C, contrasted with the value of 57.5 °C in the absence 
of sodium chloride (see Table I). This increase of T is the result of 
m 
the decreased electrostatic repulsion between the phosphate groups of 
DNA in the presence of salts (Schildkraut and Lifson, 1965). At a 
5 -4 total drug concentration of 10- M and DNA concentration of 1.66x10 M, 
Miracil D increased the metling temperature of DNA by 2 °C, while 
methyl~iracil D had no effect at all (the corresponding values in the 
absence of sodium chloride are 13.5 and 6 °C, respectively; see text 
above). 
111.4.2. Circular Dichroism Measurements at Elevated Temperatures 
Clearly as a result of drug reintercalation {see preceding 
section), the binding ratio r for the intact regions increases as the 
melting process is propagated. Since the differential molar extinction 
coefficient EL-ER is dependent on the binding ratio, it was of interest 
126 
to investigate the dependence of E1 -ER of Miracil D-DNA complexes as 
the temperature is increased. 
III.4.2.1. Miracil D-DNA Complex at Low Binding Ratios 
The dependence of the normalized absorbance change bAn of the 
Miracil D-DNA complex on the temperature (Figure 32, curve a) suggests 
that no drug is released from the complex for temperatures lower than 
55 °C. This is not surprising since uncle~ these conditions the DNA is 
far from being saturated (r=0.059 at 25 °C) and the intrinsic associ-
ation constant remains within a fairly narrow range (1.2x106 ~-1 at 
0 5 -1 0 25 C, see section III.2.1, and 2.2x10 M at 55 C, obtained from the 
van't Hoff plot, see section III.2.3). However, over the same tempera-
ture range the differential molar extinction coefficient E1 -ER de-
creases by about 20% (Figure 32, curve b), apparently due to gradual 
conformational change in the complex. This probably results from a 
modification of the electronic and magnetic interactions which produce 
changes in the rotational strength. The rate of the change in E1 -ER in 
this temperature range is -2.8x10-2 liter•Mole-1·cm-1•°C-1 • 
Above 55 °C, however, Miracil D is continuously released from 
the complex with increasing temperatures as suggested by the increases 
noted in the normalized absorbance change (Figure 32, curve a). The 
rate of the change in E1 -ER in this temperature range is -7.8xl0-
2 
-1 -1 0 -1 0 liter•Mole •em • C , i.e. 2.8 times faster than below 55 C. This 
increased rate appears to be the result of the gradual conformational 
changes noted below 55 °C (and continued at temperatures over 55 °C) 
and the reintercalation of Miracil D (see section III.4.1) which occurs 
during the course of the melting process. Assuming that the rate of 
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Figure 32. The dependence of (a) the normalized absorbance change AA 
n 
at 440 nm, (b) the differential molar extinction coefficient EL-ER at 
347 nm, and (c) the differential molar extinction coefficient EL-ER 
corrected for conformational changes at 347 nm (dashed line, see text 
for details) on the temperature of Miracil D-eal£ thymus DNA 
0.01 M sodium acetate buffer, pH 5.0 and 1 em cell. DNA concentration: 
8.4x10-4 M and Miracil D concentration: 5x10-S M. Under these con-
ditions the binding ratio r is 0.059 at 25 °C. 
0 0 yo-
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the change in EL-~ due to conformational change in the complex below 
55 °C is maintained for temperatures above 55 °C, the experimentally 
observed differential molar extinction coefficient EL-ER can be ad-
justed so as to obtain EL-ER values, the changes of which may repre-
sent the reintercalation of Miracil D during melting. The corrected 
~-ER curve is presented in Figure 32 (curve c, dashed line), which was 
constructed by drawing a tangent to curve b (Figure 32) at 55 °C with a 
-2 -1 -1 0 -1 -2 -2 
slope of 5x10 liter•Mole •em • C (=7.8x10 -2.8x10 ). 
Thus the corrected EL-ER curve may represent the change in circu-
lar dichroism due simply to reintercalation of ~uracil D. At the onset 
of DNA melting (around 55 °C), the binding ratio of the complex is about 
0.059 (no drug is released between 25 and 55 °C). Between 55 and 90 °C 
the corrected EL-ER values decrease by a factor of 2.5. A decrease in 
EL-ER values by the same factor of 2.5 is obtained if the binding ratio 
is increased from 0.059 to 0.23 using data on the dependence of the 
differential molar extinction coefficient on the binding ratio (Figure 
22). A ratio of 0.23 is obtained by the end of the melting process, 
0 i.e. around 90 C. Since at the point of saturation the binding ratio 
is 0.25, a binding ratio of 0.23 indicates that· at the end of the 
melting p~ocess the DNA is almost completely saturated with Miracil D. 
111.4.2.2. Miracil D-DNA Complex at High Binding Ratios 
For a Miracil D-DNA complex in which the DNA is almost satu-
rated by the drug at room temperature (i.e. r=0.22 at 25 °C), there-
lease of drug occurs at lower temperatures so that both the release and 
the decrease of differential molar extinction coefficient EL-ER are in-
itiated concurrently at 25 °C (Figure 33, curves a and b). The EL-ER is 
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linearly dependent on the temperature in the whole temperature range 
studied, including the melting region (from 80 to 90 °C, see Figure 33, 
curve b) of DNA. -2 -1 The rate of change in EL-ER is -2.2xl0 · liter•Mole • 
-1 0 -1 
em • C . The constancy of this rate throughout the whole temperature 
range, including the melting region of DNA, suggests that the same 
process takes place in the course of DNA melting as prior to DNA 
0 
melting (below 80 C). Furthermore, the similarity of this rate of 
change in EL-ER to that of a Miracil D-DNA complex of low binding 
-2 -1 -1 0 -1 
ratios prior to melting (-2.8x10 liter•Mole •em • C , see preceding 
section) suggests that the conformational change which takes place in 
the whole temperature range studied is not accompanied by reinterca-
lation and, therefore, is a change analogous to that which takes place 
with Miracil D-DNA complex at low binding ratios and below 55 °C. This 
finding is in agreement with expectation, since the DNA is almost satu-
rated with the drug at room temperature, and consequently there are no 
free binding sites for reintercalation. 
The results presented here and the preceding section are quite 
convincing in favour of the operation of the reintercalation process in 
the Miracil D-DNA system. It should be also noted that in order for re-
intercalation to take place, the rate of the change of the intrinsic as-
sociation constant with temperature in the melting region must be 
smaller than the rate of DNA denaturation. This requirement seems to be 
fulfilled for Miracil D. However, inspection of the melting tempera-
tures (at 260 nm) and the corresponding drug-DNA dissociation transition 
temperatures (at 440 nm) of methyl-Miracil D-DNA complexes (see Table I) 
indicates that reintercalation does not take place ( the temperatures at 
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Figure 33. The dependence of (a) the normalized absorbance change 6A 
n 
at 440 nm and (b) the differential molar extinction coefficient EL-ER 
at 347 nm on the temperature of Miracil D-eal£ thymus DNA complex in 
0.01 M so~ium acetate buffer, pH 5.0 and 1 em cell. DNA concentration: 
1.68xl0-4 M and Miracil D concentration: 5x10-5 M. Under these con-
ditions the binding ratio r is 0.22 at 25 °C. 
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the two wavelengths are identical). It is possible, ther~fore, that 
the above requirement is not satisfied in the case of methyl-Miracil D-
DNA system. 
III.4.3. Stabilization of the DNA Helix by Miracil D and Methyl-
Miracil D 
Because of the dissociation of drugs from the drug-DNA complexes 
at elevated temperatures, the binding ratios of these complexes are 
clearly smaller at the onset of DNA melting than they are at 25 °C. As 
melting progresses, however, the binding ratio of the intact regions 
increases rather than decreases du~ to reintercalation (see sections 
!11.4.1 and III.4.2). In order to compare each drug with respect to 
its effectiveness in stabilizing the double helix, the state of the 
complex at the melting temperature at 260 nm was chosen for the 
standard state of the complex. At this temperature, 50 % of the binding 
sites are assumed to be denatured, meaning that the effective nucleic 
acid concentration at these temperatures is half of that at 25 °C. The 
binding ratios at these temperatures were obtained from the binding 
ratios at 25 °C and the observed normalized absorbance changes at 440 
nm. The difference 6Tm between the melting temperatures in the 
presence and absence of drug measures the degree of stabilization 
caused by each drug. The results of these calculations are summarized 
in Table II, and the dependence of stabilization bT on the binding 
m 
ratio at the Tm of the drug-DNA complex is presented in Figure 34. 
Surprisingly, a linear relationship is obtained, and the experi-
mental points for both Miracil D and methyl-Miracil D fall on the same 
line. Consequently, the drugs, when bound to DNA, appear to stabilize 
Table II 
The extent of thermal stabilization (6Tm) of calf thymus DNA by Miracil D and methyl-Miracil D 
in 0.01 M sodium acetate buffer, pH 5.0 and the binding ratios of Miracil D-DNA and methyl-
Miracil D-DNA complexes at the melting temperatures (at 260 nm). 
T of DNA T of drug- Stabili- r 8An r (~60 nm), DWA complex zation (at 25 °C) (at T of (at T of 
oc (260 nm) , °C 8T °C complfex) complfex) m' 
57.5 71 13.5 0.059 0.32 0.080 
Miracil D 57.5 77 19.5 0.110 0.52 0.110 
57.5 84 26.5 0.220 0.64 0.160 
57.5 63.5 6 0.051 0.65 0.036 
Methyl-Miracil D 
57.5 71.5 14 0.170 0.74 0.088 
The values of r at T of the drug-DNA complexes were calculated according to the equation 
m 
r(at T of complex)=2•r(at 25 °C)•[1-8A (at T of complex)] m n m . 
-w ~ 
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Figure 34. The effectiveness of Miracil D (e) and methyl-Miracil D <•> 
in stabilizing calf thymus DNA in 0.01 ~sodium acetate buffer~ pH 5.0 
against heat denaturation. Binding ratios of drug-DNA complexes at the 
melting temperatures are indicated in the abscissa. 
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calf thymus DNA equally well. Therefore, previously reported data 
which indicate that Miracil D is much more effective in stabilizing 
calf thymus DNA against heat denaturation (Hirschberg et al., 1968c) 
than its methyl derivative are the result of the differences in the 
binding characteristics of these two compounds. 
III.S. The Inhibition of RNA Synthesis by Thioxanthenones 
III.5.1. The RNA Synthesis Assay at pH 7.0 
137 
Assays of RNA synthesis by DNA dependent RNA polymerase in the 
literature are .generally carried out at pH 8.0, which is the pH opti-
mum of the enzyme (Chamberlin and Berg, 1962). However, because of the 
very limited solubility of Miracil D at pH 8.0 and the difficulties in 
preparing soluble Miracil D-DNA complexes at this pH, the investi-
gations on the inhibition of DNA dependent RNA polymerase by Miracil D, 
methyl-Miracil D as well as MDMT were carried out at pH 7.0. At this 
pH, the enzymic activity is 62 % of its maximum value (Chamberlin and 
Berg, 1962). 
In order to establish the conditions for the reaction at pH 7.0, 
the synthesis of RNA as a function of reaction time was first investi-
gated using calf thymus DNA as template (Figure 35). The reaction is 
linear with time for the first 8 minutes, and then it slows down ap-
preciably. The time course of the reaction follows roughly first order 
kinetics, and the decrease in the rate of RNA synthesis cannot be ac-
counted for simply by substrate depletion. The cessation of RNA synthe-
sis after long reaction times is not peculiar to the pH conditions used 
for the assay, since similar kinetics have been observed under a varie-
ty of conditions (Hurwitz et al., 1962; Kozlov, 1971). A reaction time 
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Figure 35. The kinetics of RNA synthesis. Enzyme concentration: 
7.9 units/ml and calf thymus DNA concentration: 30 ~g/ml. 
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of 8 minutes was selected in all subsequent assays for which a calf 
thymus DNA template was used. When using T2 bacteriophage DNA as 
template, the rate of RNA synthesis was constant in the first 10 
minutes of the synthesis. 
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The dependence of RNA synthesis on the concentration of calf 
thymus DNA was also investigated, and the results are presented in 
Figure 36. Although the plot resembles the usual Michaelis-Menten 
hyperbolic relationship, the corresponding Lineweaver-Burk plot does 
not yield a straight line. The concentration of calf thymus DNA, at 
which half of the maximum incorporation is obtained, is about 10 ~g/ml. 
This value is in contrast to 4.8 ~g/ml reported at pH 7.5 {Hurwitz et 
al., 1962). 
For the inhibition studies using calf thymus DNA as template, a 
DNA concentration of 23 ~g/ml was selected. This value represents a 
compromise between two counteracting requirements: a template concen-
tration small enough to be rate limiting, but large enough to produce 
significant incorporation of radioactive label. 
III.5.2. The Inhibition of RNA Polymerase by Miracil D, Methyl-
Miracil D, and MDMT 
The inhibition of DNA dependent RNA polymerase by Miracil D, 
methyl-Miracil D, and MDMT was investigated under the experimental con-
ditions described in the preceding section. The experiments were per-
formed as outlined in section II.11, and the results are presented in 
Figures 37 and 38. 
It is apparent that all three drugs inhibit RNA synthesis. 
Methyl-Miracil D and MDMT appear to be equally effective when compared 
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Figure 36. The dependence of RNA syntheis on the template (calf thymus 
DNA) concentration. Enzyme concentration: 7.6 units/ml. 
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Figure 37. The inhibition of RNA synthesis by Miracil D. Enzyme concen-
tration: 10 units/ml, calf thymus DNA concentration: 23 pg/ml, and 
nucleoside triphosphate concentration: 0.5 mM (each). 
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Figure 38. The inhibition of RNA synthesis by methyl-Miracil D (e) 
and MDMT (.A). Enzyme concentration: 10 units/ml, calf thymus DNA 
concentration: 23 llg/ml, and nucleoside triphosphate concentration: 
0.5 mM (each). 
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on the basis of the total concentration of drugs present in these so-
lutions (Figures 38). In contrast, Miracil Dis an order of magnitude 
more effective {Figure 37) than the two other derivatives. 
This difference between Miracil D and its methyl derivative was 
expected in view of the results of an earlier investigation (Hirschberg 
et al., 1968c). Using a similar test system, Hirschberg and his co-
workers -reported that Miracil D causes a 90 % inhibition of RNA polymer-
ase activity, while methyl-Miracil D is completely ineffective at a 
-5 drug concentration of SxlO M. The minor quantitative differences be-
tween these reported results and the results of the present investi-
gation may be due to the differences in assay conditions. Hirschberg 
and his coworkers used salmon sperm DNA at a concentration of 70 ~g/ml, 
in contrast to calf thymus DNA of 23 ~g/ml. Also the assay was per-
formed at pH 7.9, in contrast to a pH 7.0 used for the present experi-
ments. 
The above comparison of Miracil D and methyl-Miracil D with re-
spect to their effectiveness as inhibitors of RNA polymerase is obvi-
ously based on total drug concentrations. However, since Miracil D and 
its methyl derivative bind to DNA to different extents, the observed 
differences toward RNA polymerase may be apparent rather than real and 
could simply be the result of the different binding capacity of these 
drugs to DNA. 
III.S.3. Comparison of the Effectiveness of Miracil D and Methyl-
Miracil D to Inhibit RNA Synthesis 
As noted in the previous section, the observed apparent differ-
ences in the effectiveness of Miracil D and its methyl derivative in in-
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hibiting RNA synthesis may be the result of the differences in their a-
bility to bind to DNA. In order to make the proper comparison, the 
inhibition caused by the drugs should be determined as a function of 
bound drug concentrations rather than total drugs present in the assay 
mixtures. This treatment obviously requires knowledge of the intrinsic 
association constants of drugs with DNA under the conditions of RNA 
polymerase assays. 
As noted previously (see section III.2.4), the binding of 
methyl-Miracil D to calf thymus DNA under the conditions of RNA synthe-
sis cannot be accurately determined by the spectrophotometric method 
used in this investigation. However, this binding can be estimated in-
directly from absorbance measurements (Figure 30, curve c) carried out 
in 0.01 M sodium acetate buffer, pH 5.0 using the method outlined in 
section II.10.3. Under these conditions, it can be calculated that the 
intrinsic association constant K for methyl-Miracil D decreases 5.7-
fold from 1.7x105 to 3x104 M-1 as the temperature increases from 25 to 
37 °C. Also from absorbance measurements in 0.01 M sodium acetate 
buffer, pH 5.0 at ionic strengths of 0.01 and 0.07 M (adjusted by the 
addition of 1M KCl solution), it is estimated that the intrinsic as-
sociation constant Kat 25 °C decreases 34-fold from 1.7x105 to 5x103 
M- 1 as a result of the increase in ionic strength. Since no binding 
whatsoever can be detected at an ionic strength of 0.2 M, the value of 
3 -1 5x10 M may be assumed to be the upper limit for the association 
constant at an ionic strength of 0.2 M. If the effects of temperature 
and ionic strength are asssumed to be additive, then the intrinsic as-
sociation constant of the binding of methyl-Miracil D to calf thymus DNA 
under assay conditions cannot be greater than 1.7x105/(34x5.7)= 
2 -1 8.8x10 M • 
Using the directly obtained value of 1.35x104 ~-1 for the in-
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trinsic association constant of the binding of Miracil D to calf thymus 
DNA under assay conditions (see section III.2.2) and the value of 
8.8x102 M- 1 for the estimated intrinsic association constant of the 
binding of methyl-Miracil D to calf thymus DNA under assay conditions~ 
the bound drug concentrations and the binding ratios under the con-
ditions of the .assay can be calculated as outlined in Appendix B. The 
synthesis of RNA as a function of the binding ratios for Miracil D and 
its methyl derivative are presented in Figure 39. Clearly, both 
Miracil D and methyl-Miracil D, when bound to DNA, inhibit RNA synthe-
sis with equal effectiveness. It may also be noted that the observed 
inhibitory behaviour of the bound forms of the two drugs parallels 
their effectiveness in stabilizing DNA against heat denaturation (see 
section III.4.3). This. parallelism of the drugs in the two test systems 
is further discussed in section IV.S. 
III.5.4. Miracil D: An Inhibitor of RNA Chain Initiation and 
Elongation 
In the enzymatic synthesis of RNA, there are four major steps 
(Chamberlin, 1974, see section I.6.3): template binding, RNA chain in-
itiation, RNA chain elongation, and termination. An inhibitor can 
exert its effect on any of these steps. It has been shown that the re-
ciprocal initial velocity 1/vi of the overall reaction (as determined 
in the present experiments by 3H incorporation) is linearly dependent 
on the binding ratio r, if only the elongation step is inhibited (Hyman 
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Figure 39. The inhibition of RNA synthesis by Miracil D (e) and methyl- ) 
Miracil D (0) as the function of the binding ratio r. Enzyme concen-
tration: 10 units/ml, calf thymus DNA concentration: 23 pg/ml, and 
nucleoside triphosphate concentration: 0.5 mM (each). 
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and Davidson, 1970). For,Miracil D and its methyl derivative, the de-
pendence of the reciprocal initial velocity 1/v. on the binding ratio 
~ 
r is shown in Figure 40. In the ra~ge of binding ratios from 0 to 0.05 
a linear relationship is obtained, indicating that the kinetics of 
inhibition are compatible with the inhibition of the elongation step. 
At binding ratios greater than 0.05, however, deviations from 
linearity are observed. In order to determine whether these deviations 
are a consequence of inhibition of the initiation of RNA synthesis, 
the incorporation of both 32P and 3H in RNA were investigated using T2 
bacteriophage DNA as the template. Since an RNA molecule retains the 
y-phosphate group of the first nucleotide residue involved in its 
synthesis, the incorporation of y-[ 32P]-ATP measures the number of RNA 
chains synthesized starting with ATP (Richardson, 1973). In contrast, 
the incorporation of ring labeled [ 3H]-UTP measures the total amount of 
RNA synthesized. Preliminary experiments indicated that the rate of 
RNA synthesis using T2 DNA as template is constant for at least 10 
minutes of incubation. 
In the case of Miracil D, it is apparent (Figure 41) that the 
reciprocal initial velocity 1/vi of the total RNA synthesis increases 
with r up to a binding ratio of about 0.05. At higher r values, the 
reciprocal initial velocity increases much more rapidly. The incorpo-
ration of 32P label, however, remains constant for r values lower than 
0.05, indicating that Miracil D does not inhibit initiation. Clearly, 
the same number of chains is synthesized regardless of the concentration 
of the inhibitor. For binding ratios greater than 0.05, however, the 
incorporation of 32P label decreases somewhat. This is an indication 
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Figure 40. The dependence of the reciprocal initial velocity 1/v1 of 
RNA synthesis on the binding ratio r in the presence of Miracil D (e) 
and methyl-Miracil D (0). Enzyme concentration: 10 units/ml, calf 
thymus DNA concentration: 23 ~g/ml, and nucleoside triphosphate concen-
tration: 0.5 mM (each). 
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Figure 41. The dependence of the reciprocal initial velocity 1/v. (e) 
1 
and of the initiation <•) of RNA synthesis on the binding ratio r in 
the presence of Miracil D. Enzyme concentration: 20 units/ml, T2 DNA 
concentration: 10 pg/ml, and nucleoside triphosphate concentration: 
0.5 mM (each). 
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that at higher binding ratios Miracil D interferes also with the in-
itiation step of RNA synthesis. It seems likely, though no experi-
ments were conducted, that methyl-Hiracil D behaves similarly. 
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A good correspondence in the dependences of the reciprocal in-
itial velocity on the binding ratio may be noted for T2 DNA and calf 
thymus DNA shown in Figures 40 and 41. Deviations from linearity 
start at binding ratios of about 0.05 for both templates. 
CHAPTER IV 
DISCUSSION 
IV.l. The Structure of the Miracil D-DNA Complex 
The binding of Miracil D to DNA takes place through an interca-
lation process as a result of which the drug becomes inserted between 
adjacent base pairs of DNA {see section !.6.2). As the case is with 
other intercalators, the major forces stabilizing the complex are 
probably the result of dipole-dipole, dipole-induced dipole, and 
fluctuation dipole-induced dipole {dispersion forces of London) inter-
actions between the planar aromatic Miracil D molecule and the DNA base 
pairs (Gersch and Jordan, 1965). Maximum stabilization by dispersion 
forces is obtained when the overlapping of molecular orbitals of the 
drug and the bases is maximal. This requirement is satisfied only with 
the proposed model of Miracil D-DNA complex (Weinstein and Hirschberg, 
1971) in which the long axis of the Miracil D molecule is parallel 
with those of the base pairs forming the binding site. In this complex 
the electrostatic interactions between the side chain of the drug and 
the phosphate backbone of DNA are well-accomodated (see section !.6.2), 
but the dipole-dipole interactions are not necessarily at their maxi-
mum. Since the dipole moment vectors of the four bases forming the 
binding site and of the intercalated Miracil D molecule show into five 
different directions, it is hard to predict whether stabilization or 
destabilization by dipole-dipole interactions takes place. 
It has been shown in the case of proflavine-DNA complexes 
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(Gersch and Jordan, 1965) that permanent dipole moments do not seem to 
play a decisive role in the orientation of the intercalated drug mole-
cule in the binding sites. Free energy calculations suggest that a 
hypothetical rotation of intercalated proflavine causes less than 1 
Kcal/Mole fluctuation in the ~G0 of the intercalation process. 
IV.2. The Binding of Miracil D to DNA- The Exclusion Model 
In the analysis for the interaction of drugs with nucleic acids, 
certain formulations can serve as useful diagnostic tools in the 
testing of specific binding models. One of the simplest models for the 
interaction of small ligand molecules with proteins was developed by 
Scatchard (Scatchard, 1949). According to this model, if the binding 
of a ligand molecule to the protein does not influence the binding of 
other ligand molecules to the same protein molecule, then the binding 
isotherm has the following form: 
r 
----=n·k-k·r 
cf 
where r is the binding ratio as previously defined, k is the in-
trinsic association constant, and n is the number of binding sites for 
the ligand on the protein molecule. In the Scatchard plot, this iso-
therm represents a straight line with a slope of -k and with an inter-
cept of n·k. The intercept with the r axis is n. 
The same approach can be used for the interaction of drug mole-
cules with nucleic acids. In this case the nucleic acid concentration 
is generally expressed as nucleic acid phosphorous concentration, and, 
therefore, the intercept with the r axis gives the number of binding 
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sites for the drug per nucleic acid phosphorous. If all potential 
intercalating sites were to bind drug molecules, the number of binding 
sites would be 0.5 per DNA phosphorous. In practice this is not real-
ized. Scatchard plots for drug-nucleic acid interactions take a varie-
ty of forms, most often not linear, and the number of binding sites is 
much less than 0.5, generally ranging between 0.15 and 0.25 (e.g. 
Waring, 1965; MUller and Crothers, 1968; Peacocke and Skerrett, 1956; 
Tubbs et al., 1964). Deviations from linearity are generally observed 
at the higher binding ratios. 
In order to overcome the obvious difficulties in the interpre-
tation of curved Scatchard plots, and in order to explain the lower 
than expected number of binding sites, the exclusion model was intro-
duced (McGhee and von Hippe!, 1974). This model is discussed in detail 
in section II.8.3. The exclusion model was, therefore, selected for 
analyzing the binding of Miracil D to DNA. The selection of this model 
was suggested by the fact that, as the case is with other drugs, at 
saturation only half of the potential DNA binding sites are occupied by 
Miracil D. 
It may be argued that base specificity in binding can also lead 
to binding in which less than the maximum of potential binding sites 
are able to participate. In fact, it has been suggested, based on the 
ability of Miracil D to inhibit DNA dependent RNA polymerase when syn-
thetic DNA templates are used, that Miracil D has a stronger affinity 
toward adenine residues (Wilson et al., 1972b). Aside from the fact 
that this evidence is not at all conclusive, about 25 % of the bases in 
calf thymus DNA are adenine, which suggests that each potential binding 
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site contains in the average one adenine residue. Hence any preference 
of Miracil D for adenine residue, if at all present, could not limit 
the maximum number of binding sites to as low a value as 0.25. 
Specificity toward base pairs G-C or A-T could also lead to a 
decrease in the number of potential binding sites as evidenced in the 
case of actinomycins (MUller and Crothers, 1968). Although G-C and A-T 
base pairs are equally represented in calf thymus DNA, and could be 
responsible for the decreased number of binding sites, this is very un-
likely based on the observations of Haidle and Mandel (private com-
l!lunications to Weinstein and Hirschberg, 1971). These workers tested 
the effect of several bacterial DNA's, ranging in base composition from 
27 to 69 % G-C content, on their ability to induce spectral shifts in 
the spectrum of Miracil D and found no correlation between this proper~ 
ty and G-C content. 
Exclusion does not appear to result from simple mutual steric 
interference between bound drug molecules. Since intercalation is ac-
companied by the unwinding of the DNA double helix (Waring, 1970), the 
conformation of the binding sites adjacent to an already occupied 
binding site differs from the conformation of sites surrounded by un-
occupied adjacent sites. A computerized linked-atom modeling system 
was developed by Alden and Arnott to examine the stereochemical re-
quirements for intercalation of planar drugs into DNA (Alden and 
Arnott, 1975). All classes of conformational possibilities for ex-
tending the polynucleotide backbone were examined for their ability to 
accomodate insertion of a drug into a base-paired region of DNA com-
patible with adjacent regions of DNA while stacking interactions, 
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steric strain, and non-bonded interatomic contact were opt-imized. One 
conformation was found which proved superior to all others in ability 
to satisfy these criteria. This conformation was obtained by the ex-
tension of the backbone by characteristic changes in two torsion angles 
to trans values and a change in one sugar puckering to relieve strain 
in an adjacent residue. The turn angle distributed over three poly-
nucleotide residues for this most general mode of interaction is 90 °, 
corresponding to a helical unwinding of 18 ° for ~NA. This value is in 
good agreement with the unwinding angle of 16.4 ° discussed in section 
I.6.2. It is possible that this conformational change makes the 
nearest neighbour sites so stable that binding to them becomes thermo-
dynamically unfavourable. As an alternative, it is also possible that 
binding of drug molecules to nearest neighbour sites imposes such a 
restriction on the bond angles that the binding sites cannot undergo 
the conformational changes necessary to accomodate the intercalated 
drug molecule. Independent evidence for the exclusion model is also 
obtained from X-ray crystallographic studies the results of which have 
suggested that in the ethidium bromide-DNA complex the nearest neighbor 
binding sites are excluded from binding (Jain et al., 1973). 
Under the conditions of the present binding studies (see section 
III.2.1), Miracil Dis present as a positively charged monomer (see 
section III.1), ,and, therefore, these studies deal with the interaction 
of the monomeric form of the drug wi. th DNA. The intrinsic associ-
6 4 -1 
ation constant was found to change from 1.2xl0 to 4.5x10 M when the 
ionic strength is increased from 0.01 to 0.2 M. This drastic decrease 
of K is consistent with the structure of the Miracil D-DNA complex pro-
163 
posed by Hirschberg (see section !.6.2). In this complex~ the terminal 
nitrogen atom of the side chain interacts with the negative phosphate 
backbone of the DNA. This electrostatic interaction is obviously re-
duced at high ionic strength simply because of the unfavourable compe-
tition between the negative phosphate groups and the more numerous 
cations of the buffer for the positive distal nitrogen atom. This is 
by no means to say that this electrostatic interaction is completely 
abolished at an ionic strength of 0.2 M. Since the ~G0 's calculated 
for the two intrinsic association constants at 0.01 and 0.2 M salt 
concentrations (see section III.2.1) are -8.2 (i.e. -R•T•ln(1.2x106)) 
and -6.3 (i.e. -R·T·ln(4.5x104)) Kcal/Mole, respectively, at least 25 % 
(i.e. (8.2-6.3)/8.2) of the forces stabilizing the complex in 0.01 M 
sodium acetate buffer, pH 5.0 appear to be electrostatic in character. 
IV.3. The Structure of the Methyl~1iracil D-DNA Complex 
Methyl substitution in Miracil D leads to steric hindrance be-
tween the carbonyl oxygen and this substituent, which necessitates the 
rotation of the side chain out of the plane of the heterocyclic ring 
system (Zilversmit, 1970). The ring system of methyl~iracil D, how-
ever, remains planar, and there seems to be no reason why the drug 
could be prevented from intercalating. CPK model building of the 
methyl-Miracil D-DNA complex shows that intercalation is sterically 
possible, although the conformation of the side chain may limit some-
what the depth of drug penetration between the base pairs of the double 
helix. In this conformation, the interaction between the positive 
distal nitrogen atom of the drug and the negative phosphate backbone of 
DNA appears to be still possible, but it is not as readily achieved as 
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with Miracil D. As a result, the electrostatic interactions involved 
are expected to be reduced which could explain the smaller intrinsic 
association constant observed for the binding of methyl~iracil D to 
DNA. In fact, there is a difference of 1.1 Kcal/Mole (=8.2-7.1) in the 
AG0 's of the binding of Miracil D and methyl-Miracil D to calf thymus 
DNA in 0.01 M sodium acetate buffer, pH 5.0 at room temperature {see 
sections III. 2.1 and III. 2. 4). The lowered intrinsic association 
constant compared to Miracil D is certainly not incompatible with the 
intercalative mode of binding. 
The other line of evidence which strongly suggests intercalation 
of methyl-Miracil D comes from the similarities in the circular dichro-
ism spectra of the DNA complexes formed with Miracil D and methyl-
Miracil D. This will be discussed in detail in section IV.4. 
As for the applicability of the exclusion model for the binding 
of methyl-Miracil D to DNA, similar arguments can be advanced as in the 
case of Miracil D (see section IV.2). 
IV.4. The Circular Dichroism of }liracil D-DNA and Methyl-Miracil D-
DNA Complexes 
Both Miracil D and methyl-Miracil D are optically inactive com-
pounds but, as expected from their intercalative mode of binding {see 
sections IV.1 and IV.3), they become optically active when bound to DNA 
(Figures 20 and 24). The Aependence of their differential molar ex-
tinction coefficients on the binding ratio of the complexes formed 
(Figures 21, 22, 23, 25, 26, and 27) deviate from those of the majori-
ty of other intercalative dyes and drugs discussed in section 1.7.2. 
They deviate from group 1 in that their differential molar extinction 
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coefficients vary greatly with the binding ratios, and from group 2 
that their differential molar extinction coefficients decrease with in-
creasing binding ratios and at low binding ratios they exhibit the 
maximum circular dichroism. However, 9-aminoacridine resembles the 
characteristics of Miracil D and methyl~iracil D complexes (Dalgleish 
et al., 1969). 
Since the distribution of intercalated Miracil D and methyl-
Miracil D molecules on DNA is random (except for the nearest neighbour 
sites due to exclusion), the probability of interaction between in-
tercalated drug molecules is at minimum at low r values. At these r 
values, however, the observed differential molar extinction coef-
ficients are at their maximum values rather than being zero (in con-
trast to that of group 2 compounds, see section !.7.2). Therefore, the 
observed optical activity at low r values is the result of the inter-
action between these drugs and the asyrr~etric DNA binding sites (see 
section !.7.2). 
As r increases, the probability of interaction between bound 
drug molecules increases. Two proposals have been advanced for the 
mechanism of drug-drug interaction in terms of explaining the resulting 
optical activity (Dalgleish et al., 1969): (1) exciton interaction be-
tween drug molecules mediated through base pairs and (2) alteration of 
the conformation of neighbouring binding sites as the result of 
binding. Exciton interactions between identical monomers lead to con-
servative circular dichroism spectra (Brahms and Brahms, 1970). Since 
the circular dichroism extrema of the bound drug molecules are located 
at the same wavelengths as the absorption band maxima (see sections 
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111.3.1 and 111.3.2), the circular dichroism spectra of these drugs 
must be classified as non-conservative. Therefore, the exciton inter-
action between bound drug molecules, which is responsible for the opti-
cal activity of compounds belonging to group 2 (see section 1.7.2) 
(Jackson and Mason, 1971), can be ruled out (Aktipis and Kindelis, 
1973). Therefore, the second mechanism seems likely to describe the 
circular dichroism characteristics of Miracil D and methyl~iracil D. 
The progressive binding of increasing numbers of drug molecules in the 
vicinity of molecules already bound is expected to alter continuously 
the conformation of the complex resulting in the lowered differential 
molar extinction coefficients noted at higher r values. 
The quantitative, but not qualitative differences between the 
circular dichroism of Miracil D-DNA and methyl~iracil D-DNA complexes 
could be the result of structural differences of these complexes. As 
mentioned earlier, in methyl-Miracil D the rotation of the side chain 
relative to the ring systeo limits somewhat the depth of penetration of 
the drug between the base pairs of DNA (see section 1V.3). This could 
lead to a less favourable positioni~g of the intercalated methyl-
Miracil D molecules in the binding site as compared to Miracil D. 
Since circular dichroism is very sensitive toward changes in molecular 
conformations, it seems likely that small differences in the position-
ing of bound drug molecules within the binding site could cause the 
observed differences in the resulting differential molar extinction 
coefficients. 
In the binding of Miracil D and its methyl derivative to DNA, 
further drug binding is excluded on the nearest neighbour binding sites 
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due to an indirect effect of bound drug molecules (see section IV.2). 
This exclusion effect in binding extends to only the nearest neighbour 
binding sites. However, the effect of binding appears to extend to 
sites further away than the nearest neighbour sites as evidenced from 
the dependence of the differential molar extinction coefficients on the 
binding ratio. 
In an analogous manner, the binding of actinomycin was shown to 
stabilize binding sites against heat denaturation 15 base pairs away 
(Burd et al., 1975). Therefore, the exclusion in binding and the de-
pendence of E -E on the binding ratio appears to be the result of the L R 
extension of conformational changes beyond the actual site of drug 
binding, which means that both binding exclusion and the circular 
dichroism properties of these systems are two manifestations of the same 
phenomenon. 
IV.5. The Inhibition of RNA Synthesis by '.\liracil D and Methyl-
Miracil D 
Miracil D inhibits two steps in RNA synthesis: initiation and 
elongation (see section III.5.4). Below r values of 0.05, only the 
elongation of RNA chains is inhibited, but at binding ratios greater 
than 0.05, initiation is inhibited as well. 
IV.5.1. The Inhibition of Initiation of R!~A Synthesis by Miracil D 
and Hethyl-Miracil D 
It is not quite clear why inhibition of initiation comes into 
play at an r value of 0.05, but some speculation can be advanced. For 
successful initiation to take place, the enzyme must bind to the pro-
rooter region on DNA. The bound enzyme molecule occupies about 20 con-
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secutive base pairs (Heyden et al., 1975). l-lith respect to the macha-
nism of recognition, the promoter site is selected by a random associ-
ation with and dissociation from the DNA molecule rather than by se-
lection of promoter region as a result of a sliding movement of the 
enzyme along the template. In the next step, the enzyme separates the 
two strands of the template for a length of seven or eight base pairs 
and assumes the active conformation of the enzyme-template complex 
(Chamberlin, 1974). With regard to this strand separation, RNA po-
lymerase belongs to the class of melting proteins (von Rippel and 
McGhee, 1972). Since the drug binding to DNA is a dynamic equilibrium, 
drug molecules constantly associate with and dissociate from at rates 
reflected by their rate constants. If drug molecules are bound to the 
promoter region, they could interfere with the binding of the enzyme. 
It is believed that a minimum of 12 base pairs is required to insure 
that a unique sequence of nucleotides (part of the promoter region), 
which is unlikely to be generated by random assortment of nucleotides, 
is formed so as to establish a recognition site (Thomas, 1966). Since 
drug binding by intercalation unwinds and extends the double helix, it 
appears that intercalated drug molecules distort this unique sequence 
of 12 base pairs beyond recognition by the enzyme. Therefore, it seems 
that a drug-free recognition region is necessary for selective binding 
of the enzyme to the promoter region. With increasing binding ratios, 
the probability that the recognition region is free of drug molecules 
obviously decreases. Inhibition of initiation is thus more likely to 
take place at the higher range of r values, as it has been noted ex-
perimentally for Miracil D (see section III.6.4). 
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In addition to probability considerations, kinetic consider-
ations are also important concerning the inhibition of initiation. The 
equilibrium position in the competition of drug and enzyme for the 
recognition region overwhelmingly favours the enzyme-template complex 
which is characterized by an association constant of about 1014 M-1 
(Chamberlin, 1974). Therefore, incubation of drug, template, and 
enzyme for longer periods of time and at higher temperatures before the 
onset of ru~A synthesis would be expected to decrease the inhibition of 
initiation. This has been substantiated for ethidium bromide 
(Richardson, 1973). Conversely, if drug, template, and enzyme are not 
incubated before RNA synthesis started, the inhibition of initiation 
would increase relative to the incubated assay. Indeed, actinomycin D, 
which is a strong inhibitor of RNA chain elongation (Hyman and Davidson, 
1970) and normally does not inhibit initiation, acts as an initiation 
inhibitor as well when the drug, the template, and the enzyme are not 
incubated for some time before ru~A synthesis is started (Maitra et 
al., 1967; Sentenac et al., 1968). Although this possibility was not 
investigated, it might, therefore, be expected that Miracil D would 
become a more effective inhibitor of initiation if the incubation of 
drug, template, and enzyme before the onset of RNA synthesis is re-
duced. In the view of the probability and kinetic considerations pre-
sented above, the observation that Miracil D inhibits initiation of RNA 
synthesis at r values greater than 0.05 (see section III.5.4) seems to 
be the result of two factors: (1) the dissociation rate constant of the 
Miracil D-DNA complex and (2) the period of incubation (see section 
II.11) of Miracil D, template, and enzyme before the start of RNA 
synthesis. 
If the only effect of initiation inhibitors is to prevent the 
binding of enzyme to the recognition region, then, based on the 
considerations above, drugs with low dissociation rates would be the 
most likely candidates as inhibitors of initiation. They could be 
viewed as retarding the formation of active enzyme-template complex 
simply by occupying the recognition region for extended periods of 
time. 
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The actinomycin family is an example of drugs dissociating from 
their complexes with DNA at slow rates (MUller and Crothers, 1968). 
Although actinomycin D is principally a strong inhibitor of elongation 
(Hyman and Davidson, 1970), it can inhibit &~A chain initiation (Maitra 
et al., 1967; Sentenac et al., 1968), as mentioned earlier. Therefore, 
in the comparison of the relative effectiveness of different drugs as 
inhibitors of initiation of RNA synthesis, both initiation and e-
longation inhibitors should be considered, since either type of in-
hibitor can under proper conditions inhibit initiation. At the present 
time, the comparison is not possible due to lack of such information. 
In addition, the composition of the recognition region could be a 
complicating factor, since actinomycin D binds only to G-C base pairs. 
The prevention of enzyme binding to the recognition region by 
initiation inhibitors is not the only way drugs can interfere with in-
itiation. When the active enzyme-template complex is formed, the two 
strands of the template are separated by the bound enzyme for a length 
of seven or eight base pairs (see above). Drug molecules bound in the 
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vicinity of enzyme-template complex can hinder this strand separation 
(melting-in). In the case of actinomycin binding to DNA, for instance, 
it has been found that binding increases the melting temperature of DNA 
regions as far as 15 base pairs away from the actual site of binding 
(Burd et al., 1975). This telestabilizing effect could conceivably be 
detected by the enzyme, and the rate of melting-in could thus be de-
creased. 
In this simplified overview of the mechanism of inhibition of 
initiation of RNA synthesis, both the binding and the melting-in steps 
can be interfered with by inhibitors. The present experimental data 
concerning the initiation inhibition of RNA synthesis by Miracil D (see 
section III.5.4) are not adequate to arrive at a firm conclusion 
whether Miracil D interferes with the binding or the melting-in (or 
both) steps of initiation. 
Methyl-Miracil D also inhibits RNA synthesis (see section 
111.5.3). If the intrinsic association constant estimated (see section 
111.5.3) is essentially correct, then this derivative, when bound to 
DNA, is as effective an inhibitor of ~~A synthesis as is DNA-bound 
Miracil D. Based on the similarity of the dependence of the reciprocal 
initial velocity on the binding ratio for both Miracil D and its methyl 
derivative (Figure 40), the inhibition of both elongation and initi-
ation is probable for the latter as well, although the inhibition of 
initiation by methyl-Hiracil D was not investigated separately. 
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IV.5.2. The Inhibition of Elongation of RNA Synthesis by.Miracil D 
and Methyl~iracil D 
In order to explain the relative inhibitory effectiveness of 
actinomycins as inhibitors of RNA chain elongation, it was proposed 
that this effectiveness is related also to their dissociation rate 
constants from the drug-template complex (MUller and Crothers, 1968). 
According to these authors, as the enzyme moves along the DNA template 
in the course of transcription, the enzyme will encounter intercalated 
drug molecules. As a result, RNA synthesis comes to a halt, and the 
enzyme must wait until the drug dissociates or the enzyme forces the 
drug molecule to dissociate. As the next base pair is free of drug, 
RNA synthesis can resume. A good correspondence was obtained, when 
using different synthetic and natural templates, between the relative 
effectiveness of actinomycin D to inhibit elongation and the respective 
dissociation rate constants. 
However, there are difficulties in extending the above proposal 
to every inhibitor of IDiA synthesis. Specifically, if we assume an 
average chain growth rate of 2.9 nucleotides/sec (Kozlov, 1971) (repre-
senting the incorporation of one nucleotide in 0.34 sec), drug-DNA 
complexes with a half-life much shorter than 0.34 sec would not be ex-
pected to appreciably inhibit RNA chain elongation. For ethidium 
bromide-calf thymus DNA complexes, a dissociation rate of 138 sec-l 
has been determined (Bresloff and Crothers, 1975), which suggests a 
half-life of 0.005 sec (=log 2/138). This half-life is then about 68 
e 
times shorter than the average incorporation time of one nucleotide. 
Accordingly, ethidium bromide would not be expected to inhibit &~A chain 
elongation. Contrary to expectation, however, it was found that 
ethidium bromide does inhibit elongation by about 50 % of those P~A 
molecules whose initiation has not been blocked (Richardson, 1973). 
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To reconcile this discrepancy, the mechanism of &~A chain e-
longation should be considered. In the active enzyme-template complex, 
the two strands of the template are separated for a length of seven or 
eight base pairs (see above). In the course of transcription, the 
enzyme continuously separates the two strands of the template in the 
direction of RNA chain growth, and subsequently the separated strands 
reform the double helix as the enzyme moves past them. Due to tele-
stabilization of DNA by drugs (see above), it appears that this con-
tinuous strand separation can be retarded by drug molecules bound to 
DNA many sites away from the actual site of RNA synthesis. Conse-
quently, in order for the enzyme to elongate RNA chains uninhibited, it 
seems that a long stretch of base pairs must be free of drug in the di-
rection of Rl~A chain growth. At higher binding ratios, this is equiva-
lent to the simultaneous dissociation of a number of inhibitor mole-
cules from the complex within a region of several base pairs extending 
in front of the enzyme. Therefore, if telestabilization plays an 
active role in the inhibition of elongation, the half-life of drug-DNA 
complexes may not be an appropriate measure for judging the expected 
effectiveness of inhibition. Rather the simultaneous half-life of many 
complexes should be considered. However, no experimental data are 
available on the telestabilization of DNA by ethidium bromide and 
a calculation of an appropriately combined half-life for several 
complexes would be an extremely complicated task. Therefore, a more 
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specific explanation as to why ethidium bromide inhibits elongation 
inspite of the short half-life in the ethidium bromide-template complex 
(discussed above) cannot be offered at the present time. 
The stabilization of DNA in the. presence of }Uracil D and 
methyl-Miracil D noted from hyperchromicity studies of both of these 
complexes (see section III.4.3) indicates that these drugs increase the 
resistance of DNA against heat denaturation. Since RNA polymerase con-
tinuously separates the two strands of DNA in the course of chain e-
longation, the inhibitory action of the bound forms of the two drugs 
toward Rl~A chain elongation (see section III.5.3) should parallel their 
effectiveness in stabilizing template DNA (see section III.4.3). 
Indeed, Miracil D and methyl-Miracil D, when bound to DNA, are equally 
effective in stabilizing DNA against heat denaturation (see section 
III.4.3) and equally effective in inhibiting ~1A polymerase (see 
section III.5.3). 
IV.6. Considerations on the ~ssociation and Dissociation Rates of 
Miracil D, Methyl-Miracil D, and MD~IT 
As a result of binding to the DNA template, both Miracil D and 
its methyl derivative inhibit ~~A synthesis. Since they are equally 
effective inhibitors of RNA chain elongation, they may be expected to 
have similar dissociation rate constants from their complexes with DNA 
(see previous section). It may be recalled that the intrinsic associ-
ation constant K of Miracil D with DNA is larger than that of the 
methyl-Miracil D (see sections III. 2.1 and III. 2.4, respectively). 
Also, the intrinsic association constant K for any binary complex 
is related to the association rate constant k and to the dissoci-
ass 
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ation rate constant kdiss through the equation 
kass K=------- . 
kdiss 
Therefore, it would appear that ~1iracil D associates with DNA faster 
than methyl-Miracil D, i.e. kass,MD > kass,MMD • Consequently, methyl-
Miracil D would be expected to have a greater activation energy for as-
sociation with DNA than Hiracil D. This seems to be a reasonable 
expectation based at least on inspection of the CPK models for the 
Miracil D-DNA complex relative to that of the methyl~iracil D-DNA 
complex (see section IV.3), which suggests that formation of the latter 
complex may require higher activation energy. 
From the present binding studies it also appears that 1-(4-
methyl-1,4-diazapentyl)-4-methyl-10-thioxanthene (abbreviated as MDMT) 
has a smaller intrinsic association constant ~1DMT (i.e. equilibrium 
binding constant) than that (~) of methyl-Hiracil D (see section 
III.2.5). On the basis of the relative magnitudes of these intrinsic 
association constants (i.e. equilibrium binding constants), the follow-
ing relationship holds: 
KMMD > KMDMI' 
or 
kass,MMD kass,MDMT 
----------- > ------------
kdiss,MMD kdiss,MDMT 
The results presented in Figure 38 indicate that MDMT and methyl-
Miracil D inhibit RNA polymerase roughly to the same extent when com-
pared on the basis of total inhibitor concentration present in the as-
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say solutions. Since MDMT has a smaller intrinsic association constant 
than methyl-Miracil D, it follows that MDMT, if it were compared on the 
basis of drug-DNA binding ratios as it should, would have been found to 
be a stronger inhibitor of RNA synthesis than methyl-Miracil D. Based 
on considerations cited in the preceding section, MDMT should, 
therefore, have a lower dissociation rate constant than that of methyl-
Miracil D, i.e. k < k diss,MDMT diss,MMD Consequently, 
kdiss,MDMT k diss,MMD 
From the two unequalities of association to dissociation rates, it 
follows that 
kd. J.ss,MMD k diss,MMD 
After multiplying by kdiss,MMD' the relationship kass,MMD > kass,MDMT 
is obtained, indicating that methyl-Miracil D associates with DNA 
faster than MDMT. 
It is not known at this time whether the formation of the MDMT-
DNA complex is accomplished by intercalation of the MDMT molecule. If 
intercalation is involved, this process would require very high acti-
vation energy, since the MDMT molecule is not planar (see section 1.2) 
and intercalation, similar to that of Miracil D with DNA, would require 
that the MDMT molecule become planar. Such a mechanism of complete 
intercalation would, therefore, be compatible with the small associ-
ation rate constant predicted above from the results of binding and 
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inhibition studies. 
A completely intercalated MDMT-DNA complex, however, would be ex-
pected in analogy to Miracil D and methyl~iracil D (see sections 
111.3.1 and 11!.3.2, respectively) to exhibit optical activity. 
Although no optical activity was observed experimentally in the case of 
MD~IT-DNA complexes (see section 111.3.3), the existence of optical ac-
tivity for MDMT-DNA complexes cannot be ruled out for the reasons e-
numerated in section 1!!.3.3. 
The possibility that partial intercalation of the MDMT molecule 
occurs by means of one of the benzene rings should also be considered, 
but such a mechanism of intercalation appears to be inconsistent with 
the slow association rate with DNA predicted above. Therefore, a com-
pletely intercalated MDMT-D~A complex is proposed, in which the non-
planar MDMT molecule becomes planar as the result of intercalation be-
tween adjacent base pairs of the DNA double helix. Of course, other 
models concerning the structure of MDMT-D~A complex cannot.on the ba-
sis of the present data be ruled out. 
In summary, the follol'Ting relationships among the intrinsic as-
sociation constants (K) and the association and dissociation rate 
constants (k) for ~Uracil D, methyl-Miracil D, and MDMT are consistent 
with the molecular structure of these compounds and with the results of 
the present binding and inhibition studies: 
I).ro > ~ > l)roMT ' 
k > k > k , and 
ass ,ND ass ,}1MD ass ,MDMT 
k. =k >k d1ss ,MD diss ,}lliD diss ,MDMT 
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In conclusion~ the binding of Miracil D and methyl-Miracil D to 
calf thymus D~A was studied by two spectrophotometric methods. Both 
drugs were found to conform to a model in which two adjacent binding 
sites cannot be occupied simultaneously. It has also been shown that 
Miracil D has a greater affinity to native DNA than methyl-Miracil D. 
However, when bound to DNA, both drugs are equally effective in stabi-
lizing DNA against heat denaturation and inhibiting DNA dependent RNA 
synthesis. 
CHAPTER V 
SUMMARY 
Miracil D, a schistosomicidal, carcinostatic, and bacteriostatic 
compound is known to bind to DNA through intercalation. In the re-
sulting complex, the planar heterocyclic ring system of the drug is in-
serted between adjacent base pairs of the DNA helix, and the positive 
diethylaminoethylamino side chain of the drug interacts with the nega-
tive phosphate backbone of DNA. The circular dichroism measurements in 
this work suggest that, as a result of the binding, the conformation of 
the neighbouring binding sites in DNA is also modified. Such a confor-
mational change may prevent the binding of drug molecules to sites 
which are adjacent to occupied sites. Consequently, when the exclusion 
in binding to the nearest neighbour sites is taken into account, an in-
trinsic association constant of 1.2x106 M-l is obtained in 0.01 M sodi-
um acetate buffer, pH 5.0 and at 25 °C. We have found that this in~ 
trinsic association constant substantially decreases with increasing 
temperature and ionic strength. 
In the case of methyl~iracil D, the intrinsic association 
constant (1.7xl05 M-1) is lower than that of the binding of Miracil D 
to DNA. In the former derivative, in contrast to Miracil D, the proxi-
mal -NR2 grouping is reported to be non-coplanar with the heterocyclic 
ring system due to steric interference. The conformation of the proxi-
mal nitrogen atom of methyl~iracil D may thus limit the depth of drug 
penetration between the base pairs of the DNA double helix, and may, 
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therefore, reduce the electrostatic interaction between the positive 
side chain of the drug and the negative phosphate backbone of DNA. 
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Both Miracil D and methyl-~Uracil D are optically inactive but 
become active when bound to DNA. The circular dichroism bands of 
Miracil D-DNA and methyl-Miracil D-DNA complexes are located at the 
absorption maxima and shoulders in the spectra of the bound drugs. The 
differential molar extinction coefficients of ~1iracil D-DNA complexes 
at 337, 347, and 447 nm and of methyl-Miracil D-DNA complexes at 335, 
353, and 405 nm decrease as the binding ratio (the ratio of the bound 
drug concentration to the DNA concentration) increases, indic.ating that 
the conformational changes in DNA, due to binding, extend to sites be-
yond the nearest neighbour binding sites. Based on the non-conserva-
tive character of the observed circular dichroism bands, it is sug-
gested that the induced optical activity is the result of the inter-
action between these drugs and the asymmetric binding sites of DNA. 
Miracil D and methyl-Miracil D stabilize DNA against heat de-
naturation as measured by the increase of the mid-transition tempera-
ture of drug-DNA complexes relative to that of native DNA. The drugs 
are equally effective in this respect when the comparison is made on 
the basis of binding ratios prevailing at the mid-transition tempera-
ture of the complexes. At low binding ratios, the reintercalation of 
Miracil D in the course of thermal denaturation of DNA is observed, as 
evidenced from circular dichroism measurements. 
Both Miracil D and methyl~iracil D inhibit DNA dependent RNA 
polymerase by inactivating the DNA template as a result of drug 
binding. These intercalators are equally effective in this respect 
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when the comparison is made at equal binding ratios of drug-DNA 
complexes. Furthermore, below a binding ratio of 0.05, Miracil D in-
hibits only the elongation step of RNA synthesis, and the reciprocal 
initial velocity of elongation is linearly proportional to the binding 
ratio of the Miracil D-DNA complex. At binding ratios greater than 
0.05, however, the initiation of &~A chains is inhibited as well. The 
equal effectiveness of Miracil D and methyl~iracil D in inhibiting RNA 
chain elongation and in stabilizing DNA against heat denaturation sug-
gests that these drugs inhibit P~~A polymerase by retarding the strand 
separation of the DNA template in the course of RNA chain elongation. 
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APPENDIX A 
A Proposed Model for the Structure of Miracil D Dimers 
in Aquaeous Media 
Dyes, which are generally derivatives of planar heterocyclic 
aromatic rings, have long been known to form molecular aggregates in 
aquaeous solutions (Rabinowitch and Epstein, 1941). Aggregation is 
generally accompanied by spectral changes and under certain circum-
stances these spectral changes can be used to quantitate the aggre-
gation process. The molecules in the aggregates are placed with their 
planes parallel to one another like coins in a stack. The aggregate 
is stabilized by dipole-dipole, dipole-induced dipole interactions and 
London dispersion forces. Charges located within the molecules gener-
ally can destabilize the aggregate. 
For Miracil D, a stacked dimer structure can also be postulated 
which produces maximum stabilization by dispersion forces. Four major 
"stacked" arrangements are possible in which the long molecular axes 
are parallel to one another. Only two out of these four arrangements 
place the molecular dipoles in an opposing arrangement favourable for 
dipole-dipole interactions. In order to obtain maximum separation of 
the positive charges carried on the diethylaminoethylamino side chain 
of the Miracil D molecule, which could destabilize the dimer, the dimer 
with diagonally located side chains should be considered as the most 
probable structure for Miracil D dimers in 0.01 and 0.2 M sodium 
acetate buffers, pH 5.0 (Figure 42). 
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Figure 42. A dimer structure proposed for Miracil D in aquaeous 
solutions. 
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The experimental results obtained in these studies are con-
sistent with the postulated dimer structure in two respects. First, 
the positively charged side chains are placed at a distance in the 
dimer that reduces the electrostatic repulsion between them to a negli-
gible level. Therefore, changes in the ionic strength should not be 
expected to influence the stability of the dimer as a result of 
shielding of the electric charges. Indeed, the experimentally de-
termined dimerization constants in 0.01 and 0.2 M sodium acetate 
buffers, pH 5.0 are found to be independent of ionic strength (see 
section 111.1). Secondly, it may be noted that upon dimerization, the 
monomeric form of Miracil D is transferred from a completely aquaeous 
environment to an environment in which only one face of the molecule is 
exposed to the aquaeous phase while the other face being placed into 
contact with a hydrophobic medium. This environmental change is ac-
companied by a red shift of the absorption peak at 330 nm as expected. 
A similar red shift in this absorption maximum of Miracil D is observed 
upon transfer of the drug from polar to non-polar solvents (Zilversmit, 
1971). 
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APPENDIX B 
The Calculation of the Binding Isotherm 
for the Exclusion Model 
For the calculation of the binding isotherms of the exclusion 
model, a computer program was used, written in CPS PL/I language. The 
program is shown below: 
1. 
z. 
CONTROLLED 
3. 
4. 
5. 
GET LIST(N); 
DECLARE A(N) CONTROLLED ,DNA(N) CONTROLLED 
,ROCF(N) CONTROLLED ,AC(N) CONTROLLED; 
IF ALLOCA(A) THEN FREE A,DNA,R,ROCF,AC; 
-ALLOCATE A,DNA,R,ROCF,AC; 
GET LIST(A,DNA,CT); 
GET LIST(AF,AB); 
,R(N) 
6. 
7. 
8. 
9. 
NEWK: GET LIST(K); 
10. 
11. 
12. 
13. 
14. 
15. 
16. 
17. 
18. 
19. 
20. 
21. 
22. 
23. 
24. 
25. 
26. 
27. 
28. 
29. 
30. 
. 31. 
IN RANGE'); 
PUT LIST('ASSOCIATION CONSTANT 
PUT LIST('ABSORBANCE OF FREE DRUG 
PUT LIST('ABSORa~CE OF BOUND DRUG 
PUT LIST('TOTAL DRUG CONCENTRATION 
DO I=2 TO N; 
R(I)=(AF-A(I))*CT/(AF-AB)/DNA(I); 
ROCF(I)=(AF-A(I))/(A(I)-AB)/DNA(I); 
END; 
I** I; 
DO I=2 TO N; 
CALL CALCA(K,CT,DNA(I),AF,AB,X); 
AC(I)=X; 
END; 
DO I=2 TON; 
PUT LIST ( ' ' ) ; 
PUT LIST (' ') ; 
PUT LIST(' 
PUT LIST ( ' ') ; 
SAMPLE II' , I) ; 
CALL CALCA(K,CT,l.015*DNA(I) ,AF,AB,ACDU); 
CALL CALCA(K,CT,.985*DNA(I),AF,AB,ACDL); 
=' ,K) ; 
=' ,AF); 
=',AB); 
=' ,CT); 
PUT LIST('LOWER ABS. LI:HIT =' ,ACDU-.003); 
PUT LIST('UPPER ABS. LIMIT =' ,ACDL+.003); 
PUt LIST('ABSORBANCE OBSERVED =',A(I)); 
IF A(I)>ACDU-.003&A(I)<ACDL+.003 THEN PUT LIST (' 
IN RAl~GE'); ELSE PUT LIST(' NOT 
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32. PUT LIST('R OBSERVED 
33. PUT LIST( 'R/CF OBSERVED 
34. PUT LIST('R THEORETICAL 
/(AF-AB)/DNA(I)); 
35. PUT LIST('R MAX. DUE TO ERROR 
CT/(AF-AB)/DNA(I)); 
36. PUT LIST ( 'R MIN. DUE TO ERROR 
CT/(AF-AB)/DNA(I)); 
37. PUT LIST('R/CF THEORETICAL 
(AC(I)-AB)/DNA(I)); 
=' ,R(I)); 
=' ,ROCF(I)); 
='~(AF-AC(I))*CT 
='~(AF-ACDU+.003)* 
~',(AF-ACDL-.003)* 
=' '(AF-AC(I)) I 
38. PUT LIST('R/CF MAX. DUE TO ERROR ='~(AF-ACDU+.003)/ 
(ACDU-.003-AB)/DNA(I)); 
39. PUT LIST('R/CF MIN. DUE TO ERROR =' ~(AF-ACDL-.003)/ 
(ACDL+.003-AB)/DNA(I)); 
40. PUT LIST('EXP. DNA CONC. =' ,DNA(I)); 
41. END; 
42. CALCA: PROCEDURE (KP ,CTP ,DNAP ,AFP ,ABP ~AP); 
43. ALPHA=(-16*KP*CTP-8*KP*DNAP-4)/16/KP/DNAP; 
44. BETA=(8*KP*CTP+KP*DNAP+2)/16/KP/DNAP; 
45. GAMMA=-cTP/16/DNAP; 
46. IF BETA<3/16 THEN RUP=4*BETA/3; ELSE RUP=.25; 
47. RLP=O; 
48. COUNT=l; 
49. HALF: RP=.5*(RLP+RUP); 
50. D=RP** 3+ALPHA*RP**2+BETA *RP+GAMMA; 
51. IF D=O THEN GO TO EXIT; 
52. IF D>O THEN RUP=RP; 
53. IF D<O THEN RLP=RP; 
54. IF COUNT>30 THEN GO TO EXIT; 
55. COUNT=COUNT+l; 
56. GO TO HALF; 
57. EXIT: AP=AFP-(AFP-ABP)*RP*DNAP/CTP; 
58. END CALCA; 
59. STOP; 
Storage area for the ~~perimental data and the calculated 
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quantities of N samples is allocated in instructions 1 through 4. Ab-
sorbances (A), nucleic acid concentrations (DNA), total drug concen-
tration (CT), absorbances of free (AF) and bound (AB) drug are re-
quested in instructions 5 and 6. The experimental values of r (R) and 
r/cf (ROCF) of the samples are calculated in instructions 12 through 
15. The theoretical absorbance (AC) of the samples with the arbi-
trary association constant (K), which is requested in instruction 7, 
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are calculated in instructions 17 through 20 using the in.ternal pro-
cedure CALCA. The theoretical absorbance is calculated on the basis 
of the actual nucleic acid concentration. An error of 1.5 % in nucleic 
acid concentration is assumed, and the absorbances (ACDU and ACDL) 
corresponding to 1.5 % and -1.5 % errors are calculated in instructions 
26 and 27. 
Since the error of absorbance measurements is superimposed on 
the error in nucleic acid concentrations, an error of 0.003 in absor-
bance is taken into account at this point (ACDU-0.003 and ACDL+0.003). 
If the experimental absorbance falls between these two limits, IN RANGE 
is printed in instruction 31. The values of r and r/cf corresponding 
to these absorbance limits and to the theoretical absobance are calcu-
lated in instructions 34 through 39. 
The internal procedure CALCA consists of instructions 42 through 
58. This procedure calculates the zero place of a polynomial of third 
degree in the 0 < RP < 0. 25 range. The notation of variables is the 
same as those in Appendix C, except that P's are added to the end of 
the variable names (in instructions 42 through 58) to signify that they 
are used in the internal procedure CALCA. 
In the approximation of the zero place, the method of interval 
bisection is used. According to this method, the interval, in which 
the zero place is located, is halved and that half is selected as the 
basis of the next approximation step, for which the polynomial at the 
endpoints of the selected interval has opposite signs. The halving is 
repeated 30 times, so that the value of RP is determined with an accu-
racy of at least 0.25/230=2.3x1o-10 . The analytical form of the poly-
nomial, and the existence and uniqueness of the zero place in the 
[0,0.25] interval are discussed in Appendix C. 
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Different values of K can be examined as to whether they fit the 
experimental points within experimental error or not by executing in-
structions 7 through 59. 
APPENDIX C 
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APPENDIX C 
Mathematical Proof for the Existence and Uniqueness of the Solution 
of Binding Isotherm for the Exclusion Model 
The binding of ligands to nucleic acids, when binding to the 
nearest neighbour sites is not allowed, can be described by equation 
r (l-4•r) 2 
----=K·----------- (4) 
cf 2•(1-2•r) 
where the binding ratio r is defined as 
cb 
r=---- ' (3) 
(P] 
and cf and cb are the molar concentrations of free and bound ligands, 
K is the intrinsic association constant, and [P] is the nucleic acid 
concentration (McGhee and von Hippel, 1974). Since for the total drug 
concentration ct we have 
using the definition of the binding ratio r, cf can be expressed as 
Substitution of cf into equation (4) produces the following relation-
ship: 
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r (l-4•r) 2 
----------=K·----------- . 
c -r·[P] 2·(1-2·r) 
t 
By defining a, e, andy as 
a=-
16·K·c +8·K·[P]+4 _______t ___________ 
, 
16·K·[P] 
8·K•c +K·[P]+2 
s=------t----. ----- , and 
16·K•[P] 
c 
y=- ----~---
16·[P] 
the binding isotherm can be written as a cubic equation of the form 
3 2 
r +a·r +s•r+y=O. 
In the interpretation of binding studies on the basis of this exclusion 
model, it is necessary to determine the value of r for given sets of 
K, ct, and [P]. Since the calculation of the roots of this cubic e-
quation by the Cardano formula is complex, a straightforward numerical 
approximation was developed. For the successful application of this 
numerical approximation, it was necessary to analyze the cubic equation 
itself. 
Defining the f(r) polynomial by 
3 2 f(r)=r +a•r +e·r+y , 
solving the cubic equation is equivalent to finding the zero places of 
the f(r) polynomial. < < Since only those r values, for which O=r=0.25, 
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have real physical meaning, solutions may be restricted to the 
[0,0.25] interval. At the endpoints of this interval f(O)=-c /(16•[P]) 
t 
and f(0.25)=1/(64·K·[P]). The values of c , K, and [P] are positive 
t 
numbers, therefore, f(O)<O and £(0.25)>0, i.e. the f(r) polynomial 
changes sign in the [0,0.25] interval. The f(r) polynomial is con-
tinuous for any r and, according to Bolzano's theorem, an r for which 
f(r)=O, where O<r<0.25, should exist. This assures that the f(r) 
polynomial has at least one zero place in the interval of interest. 
That there is no more than one zero place will be proven below. 
For this purpose, three cases will be distinguished on the basis of the 
value of S· The value of S determines whether the local extrema are 
maxima or minima. (The apostrophe will denote differentiation with 
respect to r.) 
Case 1: 8>3/16 
Since f'(0.25)=0 and f' '(0.25)=-4·8+3/4<0, the polynomial exhibits a 
local maximum at r=0.25. Since f'(4·8/3)=0 and f''(4•8/3)=4·S-3/4>0, 
the f(r) polynomial exhibits a local minimum at r=4·S/3>0.25. These 
extrema are separated by an inflection point at r=2·B/3+1/8>0.25. 
Since f'(r)=3·(1-4·r)•(4·S/3-r)/4, and each term is positive if r<0.25, 
then f'(r)>O if r<0.25. Therefore, f(r) is monoton increasing in the 
[0,0.25] interval. Hence f(r) cannot have more than one zero place in 
the interval of interest (Figure 43, curve 1). 
Case 2: s=3/16 
The f(r) polynomial has no local extrema but exhibits an inflection 
point at r=0.25 because £''(0.25)=0. 2 Since f'(r)=3·(1-4·r) /16>0 for 
any r, f(r) is monoton increasing for any r. Hence f(r) cannot have 
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Figure 43. Schematic representation of the f(r) polynomial for 
different values of 8 as parameter. (1) 8>3/16, (2) 8=3/16, and (3) 
8<3/16 (see text for details). 
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i(r) 
0.25 r 
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more than one zero place in the [0,0.25] interval (Figure 43, curve 2). 
Case 3: 8<3/16 
Since f'(4•8/3)=0 and f''(4•8/3)=4·8-3/4<0, the f(r) polynomial ex-
hibits a local maximum at r=4•8/3<0.25. Since f'(0.25)=0 and 
f''(0.25)=-4•8+3/4>0, the f(r) polynomial exhibits a local minimum at 
r=0.25. At this local minimum the polynomial is still positive because 
f(0.25)=1/(64•K•[P]). The extrema are separated by an inflection 
point at r=2•8/3+1/8<0.25. Since f'(r)=3•(1-4•r)•(4·B/3-r)/4, the f(r) 
polynomial is moncton increasing when r<4•S/3 (before the local maxi-
mum), is monoton decreasing when 4·S/3<r<0.25 (between the two ex-
trema), and is moncton increasing again when r>0.25 (after the local 
minimum). Consequently, there is only one zero place in the [0,4•8/3] 
interval. Although f(r) is monoton decreasing in the [4•8/3,0.25] 
interval, there is no zero place in this interval because the poly-
nomial is still positive at the minimum. Hence there is only one zero 
place in the [0,0.25] interval (Figure 43, curve 3). 
It can be concluded that there is one and only one zero place 
in the [0,0.25] interval regardless of the value of s. 
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